<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Labyrinthitis - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
            --banner-bg: #fef3c7;
            --banner-border: #f59e0b;
            --banner-text: #92400e;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .notice-banner {
            background: var(--banner-bg);
            color: var(--banner-text);
            border-bottom: 1px solid var(--banner-border);
            padding: 12px 16px;
            text-align: center;
            font-size: 0.95rem;
            cursor: pointer;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .header-dates {
            display: flex;
            flex-wrap: wrap;
            gap: 10px;
            margin-top: 16px;
            padding-top: 12px;
            border-top: 1px solid rgba(255,255,255,0.22);
            position: relative;
        }

        .date-chip {
            display: inline-flex;
            align-items: center;
            gap: 6px;
            background: rgba(255,255,255,0.14);
            border: 1px solid rgba(255,255,255,0.25);
            border-radius: 999px;
            padding: 5px 10px;
            font-size: 0.82rem;
        }

        .date-chip-label {
            font-weight: 600;
            opacity: 0.95;
        }

        .date-chip time {
            font-variant-numeric: tabular-nums;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-location {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-component {
            background: #f0fdf4;
            color: #166534;
        }

        .tag-complex {
            background: #faf5ff;
            color: #7e22ce;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .mapping-section {
            margin-bottom: 16px;
        }

        .mapping-item {
            padding: 10px 12px;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            background: #ffffff;
            margin-bottom: 10px;
        }

        .mapping-title {
            font-size: 0.9rem;
            font-weight: 600;
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            align-items: baseline;
            margin-bottom: 6px;
        }

        .mapping-label {
            color: var(--text-muted);
            font-weight: 500;
        }

        .mapping-notes {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
        }

        .mapping-tree {
            margin-top: 6px;
            font-size: 0.75rem;
            color: var(--text-muted);
            list-style: none;
            padding-left: 0;
        }

        .mapping-tree li {
            margin: 2px 0;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        .findings-section {
            margin-top: 12px;
        }

        .findings-title {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: var(--text-muted);
            margin-bottom: 6px;
        }

        .finding-item {
            padding: 10px 12px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .finding-statement {
            font-weight: 600;
            color: var(--text);
            margin-bottom: 6px;
            line-height: 1.5;
        }

        .finding-supporting {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Definitions */
        .definition-box {
            background: #ecfeff;
            border-left: 4px solid #0ea5e9;
        }
        .definition-box .item-name { color: #0c4a6e; }
        .definition-box .item-desc { color: #075985; }

        /* Inheritance */
        .inheritance-box {
            background: #fef9c3;
            border-left: 4px solid #ca8a04;
        }
        .inheritance-box .item-name { color: #92400e; }
        .inheritance-box .item-desc { color: #92400e; }

        .criteria-block {
            margin-top: 12px;
            padding: 12px;
            border-radius: 8px;
            border: 1px solid #bae6fd;
            background: rgba(255, 255, 255, 0.7);
        }

        .criteria-title {
            font-weight: 600;
            color: #0c4a6e;
            margin-bottom: 6px;
        }

        .criteria-meta {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .criteria-header {
            font-size: 0.75rem;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #0284c7;
            margin-top: 8px;
        }

        .criteria-list {
            margin-left: 18px;
            font-size: 0.9rem;
            line-height: 1.5;
            color: #0f172a;
        }

        .criteria-list li {
            margin-bottom: 6px;
        }

        .criteria-detail {
            display: block;
            font-size: 0.85rem;
            color: var(--text-muted);
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Phenotype TOC strip */
        .pheno-toc {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #e2e8f0;
            margin-bottom: 4px;
        }

        .pheno-toc-pill {
            display: inline-block;
            font-size: 0.78rem;
            padding: 3px 10px;
            border-radius: 12px;
            background: #dcfce7;
            color: #166534;
            text-decoration: none;
            cursor: pointer;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toc-pill:hover {
            background: #bbf7d0;
        }

        .pheno-toc-pill .pill-count {
            font-weight: 600;
            margin-left: 2px;
        }

        .pheno-toggle-all {
            font-size: 0.78rem;
            color: #16a34a;
            cursor: pointer;
            background: none;
            border: 1px solid #bbf7d0;
            border-radius: 6px;
            padding: 3px 10px;
            margin-left: auto;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toggle-all:hover {
            background: #f0fdf4;
        }

        /* Collapsible category groups */
        .phenotype-category-group {
            margin-bottom: 2px;
        }

        .phenotype-category-group summary {
            font-size: 0.85rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #16a34a;
            margin: 0;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #bbf7d0;
            cursor: pointer;
            list-style: none;
            display: flex;
            align-items: center;
            gap: 6px;
        }

        .phenotype-category-group summary::-webkit-details-marker {
            display: none;
        }

        .phenotype-category-group summary .chevron {
            display: inline-block;
            width: 16px;
            height: 16px;
            transition: transform 0.15s;
            flex-shrink: 0;
        }

        .phenotype-category-group[open] summary .chevron {
            transform: rotate(90deg);
        }

        .phenotype-category-group summary .cat-count {
            font-size: 0.75rem;
            font-weight: 400;
            color: #15803d;
            background: #dcfce7;
            padding: 1px 7px;
            border-radius: 8px;
        }

        /* Phenotype Contexts */
        .phenotype-contexts {
            margin-top: 10px;
        }

        .phenotype-contexts-toggle {
            font-size: 0.8rem;
            color: var(--text-muted);
            cursor: pointer;
            user-select: none;
        }

        .phenotype-contexts-toggle:hover {
            color: var(--primary);
        }

        .context-card {
            padding: 10px 14px;
            margin-top: 8px;
            border-radius: 8px;
            background: #ecfdf5;
            border: 1px solid #a7f3d0;
            font-size: 0.88rem;
        }

        .context-header {
            display: flex;
            flex-wrap: wrap;
            align-items: center;
            gap: 6px;
            margin-bottom: 6px;
        }

        .context-label {
            font-size: 0.72rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            padding: 2px 8px;
            border-radius: 4px;
        }

        .context-label-genetic {
            background: #dbeafe;
            color: #1e40af;
        }

        .context-label-sex {
            background: #fce7f3;
            color: #9d174d;
        }

        .context-label-population {
            background: #fef3c7;
            color: #92400e;
        }

        .context-label-age {
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-label-subtype {
            background: #ede9fe;
            color: #5b21b6;
        }

        .context-label-frequency {
            background: #dcfce7;
            color: #166534;
        }

        .context-gene-list {
            display: flex;
            flex-wrap: wrap;
            gap: 4px;
            margin: 4px 0;
        }

        .context-gene-tag {
            font-size: 0.78rem;
            font-weight: 600;
            padding: 1px 8px;
            border-radius: 4px;
            background: #bfdbfe;
            color: #1e3a8a;
        }

        .context-detail {
            font-size: 0.84rem;
            color: #065f46;
            line-height: 1.5;
        }

        .context-detail strong {
            color: #047857;
        }

        .context-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #bbf7d0;
            color: #14532d;
            font-weight: 600;
        }

        .context-onset {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-severity {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #fef3c7;
            color: #92400e;
        }

        .context-notes {
            font-size: 0.84rem;
            color: #065f46;
            margin-top: 4px;
            line-height: 1.5;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }
        .classification-header {
            font-size: 1rem;
            font-weight: 600;
            color: #4338ca;
            margin: 1.2rem 0 0.5rem 0;
            padding-bottom: 0.3rem;
            border-bottom: 2px solid #c7d2fe;
            text-transform: capitalize;
        }
        .subtype-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 0.4rem;
            margin: 0.3rem 0;
        }
        .subtype-freq-badge {
            background: #dbeafe;
            color: #1e40af;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-gene-tag {
            background: #fef3c7;
            color: #92400e;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-inheritance-tag {
            background: #ede9fe;
            color: #5b21b6;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-term-link {
            font-size: 0.8rem;
            color: #6366f1;
            text-decoration: none;
        }
        .subtype-term-link:hover { text-decoration: underline; }
        .subtype-children {
            margin: 0.4rem 0 0.2rem 1rem;
            padding: 0;
            list-style: none;
        }
        .subtype-children li {
            font-size: 0.85rem;
            color: #4338ca;
            padding: 0.1rem 0;
        }
        .subtype-children li::before {
            content: "↳ ";
            color: #a5b4fc;
        }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-link {
            text-decoration: none;
            color: inherit;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    <div class="notice-banner" role="button" tabindex="0">This resource is in its pre-alpha development stage. Content is actively being curated and may be incomplete or subject to change.</div>
    

    

    
    

    
    

    

    

    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Labyrinthitis</span>
        </nav>

        <header class="page-header">
            <h1>Labyrinthitis</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Complex</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0002008" target="_blank">
                        MONDO:0002008
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Inner ear disorders</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Inflammatory diseases</span>
                
            </div>
            
            
            <div class="header-dates">
                
                <span class="date-chip">
                    <span class="date-chip-label">Entry created</span>
                    <time datetime="2026-02-08T18:27:49Z">2026-02-08</time>
                </span>
                
                
                <span class="date-chip">
                    <span class="date-chip-label">Last updated</span>
                    <time datetime="2026-02-10T19:31:11Z">2026-02-10</time>
                </span>
                
            </div>
            
        </header>

        <!-- Stats bar -->
        
        
        
        
        
        
        
        
        
        
        
        
        
        <div class="stats-bar">
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Mappings</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Definitions</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Inheritance</div>
            </div>
            
            
            <a class="stat-link" href="#pathophysiology">
            <div class="stat-item">
                <div class="stat-value">12</div>
                <div class="stat-label">Pathophysiology</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Histopathology</div>
            </div>
            
            
            <a class="stat-link" href="#phenotypes">
            <div class="stat-item">
                <div class="stat-value">6</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#genetic">
            <div class="stat-item">
                <div class="stat-value">1</div>
                <div class="stat-label">Genes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#treatments">
            <div class="stat-item">
                <div class="stat-value">6</div>
                <div class="stat-label">Treatments</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#subtypes">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Subtypes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#differentials">
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Differentials</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#datasets">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Datasets</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#trials">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Trials</div>
            </div>
            </a>
            
        </div>

        <!-- Classifications -->
        

        <!-- Mappings -->
        

        <!-- Definitions -->
        

        <!-- Inheritance -->
        

        <!-- Subtypes -->
        
        <div class="card" id="subtypes">
            <div class="card-header">
                <div class="card-icon" style="background: #eef2ff; color: #4f46e5;">◆</div>
                <h2 class="card-title">Subtypes</h2>
                <span class="card-count">3</span>
            </div>
            
            
            
                
                
                    
                
                
            
                
                
                
            
                
                
                
            
            
                
                
                <div class="item-box subtype-box">
                    <div class="item-name">
                        Viral labyrinthitis
                        
                        <a class="subtype-term-link" href="http://purl.obolibrary.org/obo/MONDO_0001507" target="_blank">MONDO:0001507</a>
                        
                    </div>
                    <div class="subtype-meta">
                        
                        
                        
                    </div>
                    
                    <div class="item-desc">Most common form, often following an upper respiratory tract infection. Caused by viral infection of the labyrinth, most commonly by herpes simplex virus, adenovirus, or influenza viruses.
</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40225079" target="_blank">PMID:40225079</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"An 8-month-old female patient was diagnosed with meningitis, and later experienced developmental delays and hearing issues."</div>
                
                
                <div class="evidence-explanation">Case of bilateral labyrinthitis secondary to meningitis with fluctuating cochlear and vestibular symptoms over more than a decade, illustrating the long-term consequences of infectious labyrinthitis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                </div>
                
                <div class="item-box subtype-box">
                    <div class="item-name">
                        Bacterial (suppurative) labyrinthitis
                        
                        <a class="subtype-term-link" href="http://purl.obolibrary.org/obo/MONDO_0001739" target="_blank">MONDO:0001739</a>
                        
                    </div>
                    <div class="subtype-meta">
                        
                        
                        
                    </div>
                    
                    <div class="item-desc">Bacterial infection of the inner ear, typically as a complication of otitis media or meningitis. May cause permanent hearing loss and vestibular damage. Can be serous (toxin-mediated) or suppurative (direct bacterial invasion).
</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41158321" target="_blank">PMID:41158321</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Labyrinthitis ossificans (LO) is a rare pathological ossification of the membranous labyrinth, typically arising after inflammatory or infectious insults to the inner ear."</div>
                
                
                <div class="evidence-explanation">Case of advanced labyrinthitis ossificans resulting from recurrent childhood ear infections, demonstrating the progression from bacterial labyrinthitis to end-stage ossification.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                </div>
                
                <div class="item-box subtype-box">
                    <div class="item-name">
                        Serous labyrinthitis
                        
                        <a class="subtype-term-link" href="http://purl.obolibrary.org/obo/MONDO_0002006" target="_blank">MONDO:0002006</a>
                        
                    </div>
                    <div class="subtype-meta">
                        
                        
                        
                    </div>
                    
                    <div class="item-desc">Inflammation of the inner ear caused by bacterial toxins or inflammatory mediators crossing the round window membrane, without direct bacterial invasion of the labyrinth. Often occurs as a complication of acute or chronic otitis media.
</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41310738" target="_blank">PMID:41310738</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"A 34-year-old female patient of Chinese ethnicity presented with progressive vestibular dysfunction and unilateral acute otitis media complicated by serous labyrinthitis."</div>
                
                
                <div class="evidence-explanation">Case documenting serous labyrinthitis complicating acute otitis media, with progressive vestibular dysfunction as a key feature.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                </div>
                
            
        </div>
        

        <!-- Comorbidities -->
        

        <!-- Pathophysiology -->
        
        <div class="card" id="pathophysiology">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">⚙</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">12</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Pathogen entry into the inner ear</div>
                
                <div class="item-desc">Infectious agents reach the labyrinth through three main routes: (1) tympanogenic spread from the middle ear, where bacterial toxins or organisms cross the round or oval window membrane during otitis media; (2) meningitic spread via the cochlear aqueduct during bacterial meningitis; and (3) hematogenous or neurogenic spread, particularly for viral agents such as herpes simplex virus. In serous labyrinthitis, only toxins and inflammatory mediators cross the round window membrane without direct bacterial invasion, producing reversible dysfunction. In suppurative labyrinthitis, bacteria directly invade the perilymphatic space, causing severe purulent inflammation.
</div>
                
                
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        Round window of inner ear
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0002502" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-location">
                        Membranous labyrinth
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0001849" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41310738" target="_blank">PMID:41310738</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The differential impacts of toxic versus inflammatory mediators on inner ear physiology may render early combination therapy with antibiotics and glucocorticoids particularly efficacious."</div>
                
                
                <div class="evidence-explanation">Case of serous labyrinthitis complicating AOM documenting the tympanogenic route where toxic and inflammatory mediators cross from the middle ear into the inner ear.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39540706" target="_blank">PMID:39540706</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Bacterial labyrinthitis has been rarely described. Pseudomonas incrimination is even exceptional."</div>
                
                
                <div class="evidence-explanation">Case of direct bacterial invasion of the labyrinth from acute otitis media, demonstrating the suppurative tympanogenic route of pathogen entry.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38472515" target="_blank">PMID:38472515</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"We induced pneumococcal meningitis in approximately 500 C57Bl6 adult mice using live Streptococcus pneumoniae (serotype 3, 1 × 105 colony forming units (cfu) in 10 µl) injected directly into the cisterna magna of anesthetized mice"</div>
                
                
                <div class="evidence-explanation">Mouse model of pneumococcal meningitis demonstrating the meningitic route of labyrinthine infection via CSF-inner ear communication pathways.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Innate immune activation and cytokine release</div>
                
                <div class="item-desc">Following pathogen entry, resident macrophages in the labyrinth transition to proinflammatory states and secrete tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1beta), and interleukin-6 (IL-6). These cytokines drive endothelial activation and initiate the inflammatory cascade. In viral labyrinthitis, the NLRP3 inflammasome is activated, promoting IL-1beta maturation through caspase-1 and triggering reactive oxygen species production, which contributes to oxidative stress in cochlear and vestibular structures.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Macrophage
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000235" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Innate immune response
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0045087" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ⚠ ABNORMAL
    </span>
    
    
                    
                    <span class="tag tag-bio">
                        Cytokine production
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0001816" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ⚠ ABNORMAL
    </span>
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38472515" target="_blank">PMID:38472515</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"The inflammatory response to bacterial meningitis is robust and can affect all three scalae."</div>
                
                
                <div class="evidence-explanation">Mouse meningitis model demonstrating that the innate immune response to bacterial infection involves all three cochlear scalae, reflecting widespread immune activation throughout the labyrinth.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Leukocyte recruitment and infiltration</div>
                
                <div class="item-desc">Cytokine and chemokine signaling drives sequential recruitment of leukocytes into the perilymphatic spaces. Neutrophils are the first to arrive, peaking at approximately day 1. CCR2-positive monocytes and macrophages follow, with CX3CR1-positive resident macrophages also expanding. Lymphocytes increase subacutely by days 4-7, and the myeloid infiltrate peaks around day 14 in experimental models. Both CCR2 and CX3CR1 chemokine receptor pathways modulate the severity of cochlear inflammation and subsequent tissue remodeling.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Neutrophil
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000775" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        Macrophage
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000235" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Leukocyte migration
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0050900" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ⚠ ABNORMAL
    </span>
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        Scala tympani
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0001864" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38472515" target="_blank">PMID:38472515</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"Both CCR2 and CX3CR1 monocytes and macrophages were present in the cochlea in large numbers after infection."</div>
                
                
                <div class="evidence-explanation">Mouse meningitis model showing robust recruitment of CCR2 and CX3CR1 mononuclear phagocytes into the cochlea, with CCR2 knockout mice experiencing more severe hearing loss and ossification, indicating a protective role for innate immune trafficking.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Blood-labyrinth barrier disruption</div>
                
                <div class="item-desc">The blood-labyrinth barrier (BLB), a specialized non-fenestrated microvascular barrier of the stria vascularis and cochlear capillaries, is disrupted by the inflammatory response. Pericyte and endothelial cell dysfunction under inflammatory and oxidative stress increases permeability, permitting serum proteins and leukocytes into cochlear fluids. In experimental meningitis, barrier disruption is detectable by 3 days post-infection and may restore by 7 days, but the transient breach amplifies inflammatory injury and impairs strial ion homeostasis.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Pericyte
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000669" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        Endothelial cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000115" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Regulation of vascular permeability
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0043114" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ⚠ ABNORMAL
    </span>
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        Stria vascularis of cochlear duct
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0002282" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38472515" target="_blank">PMID:38472515</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"The blood-perilymph barrier was disrupted at 3 days post infection (DPI) and was restored by seven DPI."</div>
                
                
                <div class="evidence-explanation">Mouse meningitis model quantifying the temporal dynamics of blood-labyrinth barrier disruption, with breach at 3 days and restoration by 7 days post-infection.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3390/biology13100802" target="_blank">DOI:10.3390/biology13100802</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-OTHER">Other</span>
                    
                </div>
                
                <div class="evidence-snippet">"pericytes, a type of vascular mural cell specialized to maintain the integrity and function of the microvasculature, may play a crucial role in the development and progression of inner ear disorders"</div>
                
                
                <div class="evidence-explanation">Review detailing how pericyte dysfunction contributes to blood-labyrinth barrier breakdown, increased permeability, and impaired neurovascular coupling in inner ear disorders.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Vestibular neuroepithelial damage</div>
                
                <div class="item-desc">Inflammatory mediators, leukocyte infiltration, and oxidative stress damage the vestibular sensory epithelium. Hair cells in the cristae ampullares and maculae undergo injury and apoptosis, producing acute unilateral vestibular loss. The resulting vestibular tone asymmetry generates the characteristic acute vestibular syndrome with severe vertigo, spontaneous nystagmus, and postural imbalance.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Vestibular hair cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000609" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Inflammatory response
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006954" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ⚠ ABNORMAL
    </span>
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        Vestibular labyrinth
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0001862" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37621282" target="_blank">PMID:37621282</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"In the labyrinthitis group, the mean vestibulo-ocular reflex gain was 0.72 in the ipsilesional horizontal canal, 0.73 in the ipsilesional anterior canal, and 0.55 in the ipsilesional posterior canal."</div>
                
                
                <div class="evidence-explanation">Study of 27 labyrinthitis patients demonstrating vestibular dysfunction across all three semicircular canals, with posterior canal most severely affected.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Cochlear hair cell injury</div>
                
                <div class="item-desc">Inflammatory mediators, leukocyte infiltration, and oxidative stress damage hair cells in the organ of Corti. Both inner and outer hair cells undergo apoptosis, and ribbon synapses between inner hair cells and spiral ganglion neuron dendrites are disrupted, producing sensorineural hearing loss. Damage to the stria vascularis disrupts the endocochlear potential required for hair cell mechanotransduction, further impairing auditory function. Cochlear involvement distinguishes labyrinthitis from vestibular neuritis, which spares hearing.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Auditory hair cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000202" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Apoptotic process
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006915" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ⚠ ABNORMAL
    </span>
    
    
                    
                    <span class="tag tag-bio">
                        Sensory perception of sound
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0007605" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ⚠ ABNORMAL
    </span>
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        Spiral organ of cochlea
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0002227" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27435969" target="_blank">PMID:27435969</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"74 % of subjects with vertigo and SSNHL demonstrated impairment of the posterior canal gain (0.45 ± 0.20)."</div>
                
                
                <div class="evidence-explanation">Study of 27 patients with vertigo and sudden sensorineural hearing loss showing combined cochlear and vestibular involvement, with 23 diagnosed as labyrinthitis.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3390/biology13100802" target="_blank">DOI:10.3390/biology13100802</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-OTHER">Other</span>
                    
                </div>
                
                <div class="evidence-snippet">"pericytes, a type of vascular mural cell specialized to maintain the integrity and function of the microvasculature, may play a crucial role in the development and progression of inner ear disorders"</div>
                
                
                <div class="evidence-explanation">Review highlighting pericyte dysfunction in the stria vascularis as contributing to blood-labyrinth barrier breakdown and cochlear injury in inner ear inflammatory disorders.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Spiral ganglion neuron degeneration</div>
                
                <div class="item-desc">Spiral ganglion neurons in Rosenthal&#39;s canal degenerate as a consequence of direct inflammatory damage, loss of neurotrophic support from damaged hair cells, and disruption of the cochlear microenvironment. Spiral ganglion neuron loss is a major determinant of permanent sensorineural hearing loss and limits the efficacy of cochlear implantation, as the implant relies on surviving neurons for electrical stimulation.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Spiral ganglion neuron
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0011113" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Neuron apoptotic process
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0051402" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ⚠ ABNORMAL
    </span>
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        Cochlea
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0001844" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38472515" target="_blank">PMID:38472515</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"Loss of spiral ganglion neurons was common, and inner ear anatomy was distorted by scarring caused by new soft tissue and bone deposited within the scalae."</div>
                
                
                <div class="evidence-explanation">Mouse meningitis model documenting spiral ganglion neuron loss as a common consequence of meningitic labyrinthitis, with distortion of cochlear architecture.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Endolymphatic hydrops</div>
                
                <div class="item-desc">Post-inflammatory disruption of endolymph homeostasis can lead to endolymphatic hydrops. Damage to the stria vascularis impairs potassium recycling and the endocochlear potential, while injury to the endolymphatic sac or duct reduces endolymph reabsorption. The resulting fluid accumulation contributes to fluctuating hearing loss, tinnitus, and episodic vertigo in some patients during recovery or as a long-term sequela.
</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28306649" target="_blank">PMID:28306649</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Recent investigation of secondary endolymphatic hydrops has brought attention to traumatic and inflammatory insults as causes for secondary endolymphatic hydrops."</div>
                
                
                <div class="evidence-explanation">Review establishing inflammatory insults as a recognized cause of secondary endolymphatic hydrops, supporting the post-labyrinthitis mechanism.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Autoimmune-mediated inner ear damage</div>
                
                <div class="item-desc">In some cases, the initial infectious trigger provokes an autoimmune response against inner ear antigens, perpetuating inflammation beyond the acute infection. Cross-reactive antibodies against inner ear proteins (including cochlin and heat shock proteins) and T cell- mediated inflammation may drive ongoing damage. This mechanism may explain bilateral, relapsing, or progressively worsening presentations that continue after clearance of the initial pathogen.
</div>
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Immune response
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006955" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ⚠ ABNORMAL
    </span>
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        Internal ear
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0001846" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.37349/ei.2024.00129" target="_blank">DOI:10.37349/ei.2024.00129</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-OTHER">Other</span>
                    
                </div>
                
                <div class="evidence-snippet">"Various autoimmune disorders, including systemic lupus erythematosus, rheumatoid arthritis, and Sjogren&#39;s syndrome, have been implicated in immune-mediated damage to auditory structures, resulting in inner ear dysfunction."</div>
                
                
                <div class="evidence-explanation">Review documenting immune-mediated mechanisms of inner ear damage, including autoantibody-mediated and T cell-mediated inflammation affecting auditory structures.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.1097/md.0000000000033889" target="_blank">DOI:10.1097/md.0000000000033889</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Autoimmune inner ear disease typically presents with bilateral hearing loss that progresses over weeks or months though its mechanisms are unknown. Corticosteroids are the first-line treatment, but their responses are variable and relapses are frequent."</div>
                
                
                <div class="evidence-explanation">Case report and review documenting the relapsing nature of autoimmune inner ear disease and partial corticosteroid responsiveness.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Fibroblast proliferation in the labyrinth</div>
                
                <div class="item-desc">Following acute inflammation, fibroblasts proliferate within the perilymphatic spaces of the labyrinth. Inflammatory cytokines and growth factors released during the immune response stimulate fibroblast activation and expansion. The severity of fibroblast proliferation is modulated by chemokine-controlled myeloid cell trafficking, particularly through CCR2 and CX3CR1 pathways.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Fibroblast
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000057" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Fibroblast proliferation
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0048144" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ⚠ ABNORMAL
    </span>
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        Scala tympani
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0001864" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38472515" target="_blank">PMID:38472515</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"Cochlear fibrosis could be detected within 4 days of infection, and neo-ossification by 14 days."</div>
                
                
                <div class="evidence-explanation">Mouse meningitis model showing fibroblast-driven tissue remodeling as the earliest reparative response, detectable within 4 days post-infection.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Labyrinthine fibrosis</div>
                
                <div class="item-desc">Activated fibroblasts deposit extracellular matrix proteins including collagen within the perilymphatic spaces, producing fibrotic tissue that replaces normal labyrinthine structures. Fibrosis is most prominent in the scala tympani basal turn and distorts inner ear architecture, contributing to permanent sensorineural hearing loss. This fibrous stage precedes and provides the scaffold for subsequent neo-ossification.
</div>
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Extracellular matrix organization
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0030198" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ⚠ ABNORMAL
    </span>
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        Scala tympani
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0001864" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38472515" target="_blank">PMID:38472515</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"inner ear anatomy was distorted by scarring caused by new soft tissue and bone deposited within the scalae."</div>
                
                
                <div class="evidence-explanation">Mouse meningitis model documenting distortion of inner ear architecture by fibrotic soft tissue deposited within the cochlear scalae.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Labyrinthitis ossificans</div>
                
                <div class="item-desc">In the most severe cases, labyrinthine fibrosis progresses to neo-ossification, with new bone formation visible by 14 days post-infection. Osteoblast-like cells deposit mineralized tissue within the perilymphatic spaces, progressively obliterating the cochlear lumen. This labyrinthitis ossificans is most prominent in the scala tympani basal turn and causes permanent profound sensorineural hearing loss. The obliteration of cochlear architecture can prevent or severely complicate cochlear implantation, making early diagnosis and intervention critical.
</div>
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Ossification
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0001503" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ⚠ ABNORMAL
    </span>
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        Scala tympani
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0001864" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-location">
                        Membranous labyrinth
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0001849" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39670911" target="_blank">PMID:39670911</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Labyrinthitis ossificans is a pathology consisting of calcification of the membranous labyrinth resulting in profound sensory deafness. It is usually due to an acute inflammatory process that progresses to ossification of the labyrinth."</div>
                
                
                <div class="evidence-explanation">Review establishing that labyrinthitis leads to labyrinthitis ossificans through progressive calcification of the membranous labyrinth.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38472515" target="_blank">PMID:38472515</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"Cochlear fibrosis could be detected within 4 days of infection, and neo-ossification by 14 days."</div>
                
                
                <div class="evidence-explanation">Mouse meningitis model documenting neo-ossification visible by 14 days post-infection as the terminal stage of post-inflammatory cochlear remodeling.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        

        <!-- Causal Graph -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #e0e7ff; color: #4f46e5;">⬡</div>
                <h2 class="card-title">Causal Graph</h2>
            </div>
            
            <div class="mermaid-container">
                <pre class="mermaid">graph LR
    Labyrinthine_fibrosis[&#34;Labyrinthine fibrosis&#34;]
    Spiral_ganglion_neuron_degeneration[&#34;Spiral ganglion neuron degeneration&#34;]
    Fibroblast_proliferation_in_the_labyrinth[&#34;Fibroblast proliferation in the labyrinth&#34;]
    Leukocyte_recruitment_and_infiltration[&#34;Leukocyte recruitment and infiltration&#34;]
    Pathogen_entry_into_the_inner_ear[&#34;Pathogen entry into the inner ear&#34;]
    Endolymphatic_hydrops[&#34;Endolymphatic hydrops&#34;]
    Autoimmune_mediated_inner_ear_damage[&#34;Autoimmune-mediated inner ear damage&#34;]
    Innate_immune_activation_and_cytokine_release[&#34;Innate immune activation and cytokine release&#34;]
    Labyrinthitis_ossificans[&#34;Labyrinthitis ossificans&#34;]
    Cochlear_hair_cell_injury[&#34;Cochlear hair cell injury&#34;]
    Vestibular_neuroepithelial_damage[&#34;Vestibular neuroepithelial damage&#34;]
    Blood_labyrinth_barrier_disruption[&#34;Blood-labyrinth barrier disruption&#34;]

    Pathogen_entry_into_the_inner_ear --&gt; Innate_immune_activation_and_cytokine_release
    Innate_immune_activation_and_cytokine_release --&gt; Leukocyte_recruitment_and_infiltration
    Innate_immune_activation_and_cytokine_release --&gt; Blood_labyrinth_barrier_disruption
    Leukocyte_recruitment_and_infiltration --&gt; Vestibular_neuroepithelial_damage
    Leukocyte_recruitment_and_infiltration --&gt; Cochlear_hair_cell_injury
    Leukocyte_recruitment_and_infiltration --&gt; Fibroblast_proliferation_in_the_labyrinth
    Blood_labyrinth_barrier_disruption --&gt; Cochlear_hair_cell_injury
    Blood_labyrinth_barrier_disruption --&gt; Endolymphatic_hydrops
    Cochlear_hair_cell_injury --&gt; Spiral_ganglion_neuron_degeneration
    Autoimmune_mediated_inner_ear_damage --&gt; Cochlear_hair_cell_injury
    Autoimmune_mediated_inner_ear_damage --&gt; Vestibular_neuroepithelial_damage
    Fibroblast_proliferation_in_the_labyrinth --&gt; Labyrinthine_fibrosis
    Labyrinthine_fibrosis --&gt; Labyrinthitis_ossificans

    style Labyrinthine_fibrosis fill:#dbeafe
    style Spiral_ganglion_neuron_degeneration fill:#dbeafe
    style Fibroblast_proliferation_in_the_labyrinth fill:#dbeafe
    style Leukocyte_recruitment_and_infiltration fill:#dbeafe
    style Pathogen_entry_into_the_inner_ear fill:#dbeafe
    style Endolymphatic_hydrops fill:#dbeafe
    style Autoimmune_mediated_inner_ear_damage fill:#dbeafe
    style Innate_immune_activation_and_cytokine_release fill:#dbeafe
    style Labyrinthitis_ossificans fill:#dbeafe
    style Cochlear_hair_cell_injury fill:#dbeafe
    style Vestibular_neuroepithelial_damage fill:#dbeafe
    style Blood_labyrinth_barrier_disruption fill:#dbeafe</pre>
            </div>
        </div>
        

        <!-- Phenotypes -->
        
        <div class="card" id="phenotypes">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">●</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">6</span>
            </div>
            
            
            <div class="pheno-toc">
                
                <a class="pheno-toc-pill" data-target="pheno-cat-1">Digestive<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-2">Ear<span class="pill-count">(3)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-3">Eye<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-4">Nervous System<span class="pill-count">(1)</span></a>
                
                <button class="pheno-toggle-all" id="phenoToggleAll">Expand all</button>
            </div>
            
            
            <details class="phenotype-category-group" id="pheno-cat-1">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Digestive
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Nausea and vomiting
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002017" target="_blank">
                                Nausea and vomiting
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002017)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39670911" target="_blank">PMID:39670911</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The clinical manifestations are irreversible hearing loss, dizziness and vomiting."</div>
                
                
                <div class="evidence-explanation">Review listing vomiting as one of the cardinal clinical manifestations of labyrinthitis ossificans, reflecting the vestibular component of labyrinthitis.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39540706" target="_blank">PMID:39540706</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"A 18-year-old female presented with left sudden hearing loss, rotatory vertigo, vomiting, and tinnitus evolving for 24 hours."</div>
                
                
                <div class="evidence-explanation">Case of bacterial labyrinthitis documenting vomiting as a presenting symptom alongside vertigo, hearing loss, and tinnitus.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-2">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Ear
                    <span class="cat-count">3</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Vertigo
                        
                        <span class="phenotype-freq">OBLIGATE</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002321" target="_blank">
                                Vertigo
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002321)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/14977076" target="_blank">PMID:14977076</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"To evaluate the dynamic properties of the horizontal vestibulo-ocular reflex (h-VOR) in the acute stage of two common labyrinthine diseases that provoke severe attacks of vertigo with spontaneous nystagmus: vestibular neuritis (vestibular loss alone) and viral labyrinthitis (cochleovestibular loss)."</div>
                
                
                <div class="evidence-explanation">Study of 21 viral labyrinthitis patients documenting severe vertigo with spontaneous nystagmus as a cardinal feature.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Sensorineural hearing loss
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000407" target="_blank">
                                Sensorineural hearing impairment
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000407)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37621282" target="_blank">PMID:37621282</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"pure-tone audiometry, ipsilesional posterior canal gain, and gain asymmetry of posterior canal were excellent parameters for distinguishing labyrinthitis from vestibular neuritis."</div>
                
                
                <div class="evidence-explanation">Study demonstrating that sensorineural hearing loss on audiometry is the key distinguishing feature between labyrinthitis and vestibular neuritis.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39540706" target="_blank">PMID:39540706</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"A tonal audiogram showed a left perceptive deafness."</div>
                
                
                <div class="evidence-explanation">Case of bacterial labyrinthitis documenting sensorineural hearing loss confirmed on audiometry, with deafness persisting despite treatment.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Tinnitus
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000360" target="_blank">
                                Tinnitus
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000360)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39540706" target="_blank">PMID:39540706</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"A 18-year-old female presented with left sudden hearing loss, rotatory vertigo, vomiting, and tinnitus evolving for 24 hours."</div>
                
                
                <div class="evidence-explanation">Case of bacterial labyrinthitis presenting with tinnitus as part of the acute symptom complex.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-3">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Eye
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Nystagmus
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000639" target="_blank">
                                Nystagmus
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000639)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/14977076" target="_blank">PMID:14977076</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"two common labyrinthine diseases that provoke severe attacks of vertigo with spontaneous nystagmus: vestibular neuritis (vestibular loss alone) and viral labyrinthitis (cochleovestibular loss)."</div>
                
                
                <div class="evidence-explanation">Study documenting spontaneous nystagmus as a defining feature of both vestibular neuritis and viral labyrinthitis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-4">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Nervous System
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Postural imbalance
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002141" target="_blank">
                                Gait imbalance
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002141)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.1136/bcr-2023-258290" target="_blank">DOI:10.1136/bcr-2023-258290</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"We report on a boy in his early adolescence with a sudden onset of spinning sensation, imbalance and unilateral hearing loss with a positive SARS-CoV-2 test."</div>
                
                
                <div class="evidence-explanation">Case of COVID-19-induced labyrinthitis documenting imbalance as a presenting feature alongside vertigo and hearing loss.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/23648600" target="_blank">PMID:23648600</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Disorders of the inner ear can cause hearing loss, tinnitus, vertigo and imbalance."</div>
                
                
                <div class="evidence-explanation">Review establishing imbalance as a cardinal symptom of inner ear disorders including labyrinthitis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <script>
            (function() {
                // TOC pill click: expand target group and scroll to it
                document.querySelectorAll('.pheno-toc-pill').forEach(function(pill) {
                    pill.addEventListener('click', function() {
                        var target = document.getElementById(pill.dataset.target);
                        if (target) {
                            target.open = true;
                            target.scrollIntoView({behavior: 'smooth', block: 'start'});
                        }
                    });
                });
                // Expand/collapse all toggle
                var btn = document.getElementById('phenoToggleAll');
                if (btn) {
                    btn.addEventListener('click', function() {
                        var groups = document.querySelectorAll('.phenotype-category-group');
                        var anyOpen = Array.from(groups).some(function(g) { return g.open; });
                        groups.forEach(function(g) { g.open = !anyOpen; });
                        btn.textContent = anyOpen ? 'Expand all' : 'Collapse all';
                    });
                }
            })();
            </script>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card" id="genetic">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">🧬</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    Susceptibility factors
                    
                </div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card" id="treatments">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">💊</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">6</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Vestibular suppressants
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Short-term use of vestibular suppressants (benzodiazepines, antihistamines such as meclizine or dimenhydrinate, anticholinergics) to control acute vertigo, nausea, and vomiting. Should be limited to the first 48-72 hours to avoid delaying central vestibular compensation.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37953517" target="_blank">PMID:37953517</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-OTHER">Other</span>
                    
                </div>
                
                <div class="evidence-snippet">"Anticholinergics, phenothiazines, antihistamines, antidopaminergics, benzodiazepines, and calcium channel antagonists are examples of vestibular suppressants."</div>
                
                
                <div class="evidence-explanation">Review cataloging the major classes of vestibular suppressants used for symptomatic management of acute unilateral vestibulopathy.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34411472" target="_blank">PMID:34411472</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-OTHER">Other</span>
                    
                </div>
                
                <div class="evidence-snippet">"Symptomatic therapies include generalized supportive care and administration of vestibular suppressants and antiemetics."</div>
                
                
                <div class="evidence-explanation">Review establishing vestibular suppressants and antiemetics as the standard symptomatic therapy for acute vestibular neuritis, applicable to labyrinthitis management.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Corticosteroids
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Systemic corticosteroids (oral or intravenous) may be used in the acute phase to reduce inner ear inflammation and potentially improve hearing outcomes. Intratympanic steroid injection is an alternative route of administration. The evidence for efficacy is stronger for hearing recovery than for vestibular recovery.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.1136/bcr-2023-258290" target="_blank">DOI:10.1136/bcr-2023-258290</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Symptoms improved gradually with steroids and vestibular rehabilitation therapy."</div>
                
                
                <div class="evidence-explanation">Case of COVID-19-induced acute labyrinthitis in a teenager showing improvement with corticosteroid treatment and vestibular rehabilitation.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.1097/md.0000000000033889" target="_blank">DOI:10.1097/md.0000000000033889</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Corticosteroids are the first-line treatment, but their responses are variable and relapses are frequent."</div>
                
                
                <div class="evidence-explanation">Review establishing corticosteroids as first-line therapy for autoimmune inner ear disease, though with variable responses.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41310738" target="_blank">PMID:41310738</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"ceftriaxone sodium (2 g) and dexamethasone (10 mg) were administered via intravenous infusion once daily for 5 days, complemented by hydroxymethazoline and mometasone furoate nasal sprays as adjunctive antiinflammatory measures. Within a week, audiometric thresholds returned to normal, nystagmus..."</div>
                
                
                <div class="evidence-explanation">Case demonstrating complete audiometric and vestibular recovery within one week with early combination IV dexamethasone and antibiotic therapy for serous labyrinthitis.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Antiviral therapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Antiviral medications (acyclovir, valacyclovir) may be considered when viral etiology is suspected, particularly herpes simplex or varicella-zoster virus. Often combined with corticosteroids. The evidence for efficacy as monotherapy is limited.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15269315" target="_blank">PMID:15269315</a>
                    </span>
                    
                    <span class="evidence-support support-REFUTE">REFUTE</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Analysis of variance showed a significant effect of methylprednisolone (P&lt;0.001) but not of valacyclovir (P=0.43). The combination of methylprednisolone and valacyclovir was not superior to corticosteroid monotherapy."</div>
                
                
                <div class="evidence-explanation">Landmark NEJM RCT of 141 patients with acute vestibular neuritis demonstrating that valacyclovir had no significant effect on vestibular recovery, refuting antiviral efficacy for this indication.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37953517" target="_blank">PMID:37953517</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                    <span class="evidence-source source-OTHER">Other</span>
                    
                </div>
                
                <div class="evidence-snippet">"Antivirals are even more contentious in the context of AUV treatment."</div>
                
                
                <div class="evidence-explanation">Review confirming that antiviral therapy remains controversial and unsupported by robust evidence for acute unilateral vestibulopathy.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Antibiotics
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Systemic antibiotics are essential for bacterial labyrinthitis. Broad-spectrum intravenous antibiotics with good CNS and inner ear penetration are required. Surgical drainage may be necessary for suppurative labyrinthitis complicating otitis media or cholesteatoma.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39540706" target="_blank">PMID:39540706</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"She initially received probabilistic intravenous antibiotherapy associating cefotaxime to vancomycin for 17 days, then, we switched to adapt to the antibiogram. She had a total of 25 days of antibiotic therapy and 14 days of corticosteroid treatment."</div>
                
                
                <div class="evidence-explanation">Case demonstrating prolonged IV antibiotic therapy (25 days) required for bacterial labyrinthitis complicating otitis media.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Vestibular rehabilitation therapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000011" target="_blank">
                            MAXO:0000011
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Structured exercise program to promote central vestibular compensation after the acute phase. Includes gaze stabilization exercises, habituation exercises, and balance training. Early initiation (once acute symptoms subside) improves outcomes.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.1136/bcr-2023-258290" target="_blank">DOI:10.1136/bcr-2023-258290</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Symptoms improved gradually with steroids and vestibular rehabilitation therapy."</div>
                
                
                <div class="evidence-explanation">Case report demonstrating improvement with vestibular rehabilitation therapy in COVID-19-induced acute labyrinthitis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Cochlear implantation
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000451" target="_blank">
                            MAXO:0000451
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">For patients with profound sensorineural hearing loss following labyrinthitis, cochlear implantation may restore auditory function. Early implantation is important because labyrinthitis ossificans can obliterate the cochlear lumen, making electrode insertion difficult or impossible.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/26536413" target="_blank">PMID:26536413</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Nineteen (48.7%) patients had intraoperative evidence of LO. Fourteen patients (70.0%) without LO compared with seven (36.8%) with LO developed open-set speech after implantation."</div>
                
                
                <div class="evidence-explanation">Study of 39 children with post-meningitic hearing loss showing labyrinthitis ossificans negatively impacts cochlear implant outcomes.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39670911" target="_blank">PMID:39670911</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"It is important to make the correct diagnosis before cochlear implantation, as ossification of the labyrinth can hinder or prevent the implantation of electrodes."</div>
                
                
                <div class="evidence-explanation">Review emphasizing the importance of early cochlear implantation before labyrinthitis ossificans obliterates the cochlear lumen.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41158321" target="_blank">PMID:41158321</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"while cochlear implantation remains feasible in early or partial ossification, advanced cases may require alternative rehabilitation strategies. Early diagnosis is crucial for optimizing hearing outcomes."</div>
                
                
                <div class="evidence-explanation">Case of advanced LO demonstrating that cochlear implantation feasibility depends on ossification stage, with a small residual basal turn segment being the only remaining option in advanced cases.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">🌍</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Viral upper respiratory tract infection</div>
                
                
                <div class="item-desc">The most common preceding event, with viral labyrinthitis typically developing during or shortly after an upper respiratory tract infection. Viruses may reach the inner ear via hematogenous spread or direct extension along the cochlear nerve.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.1136/bcr-2023-258290" target="_blank">DOI:10.1136/bcr-2023-258290</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"We report COVID-19-induced acute labyrinthitis in a teenager."</div>
                
                
                <div class="evidence-explanation">Case report documenting SARS-CoV-2 viral infection as a trigger for acute labyrinthitis, illustrating the viral etiology pathway.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Otitis media</div>
                
                
                <div class="item-desc">Acute or chronic otitis media is the primary risk factor for serous and suppurative bacterial labyrinthitis. Bacterial toxins or organisms can cross the round window membrane to infect the inner ear. Cholesteatoma erosion into the labyrinth is another route of infection.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39540706" target="_blank">PMID:39540706</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Ten days earlier, she presented symptoms of acute media otitis."</div>
                
                
                <div class="evidence-explanation">Case report documenting bacterial labyrinthitis developing as a complication of acute otitis media, with Pseudomonas crossing from the middle ear.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41310738" target="_blank">PMID:41310738</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"A 34-year-old female patient of Chinese ethnicity presented with progressive vestibular dysfunction and unilateral acute otitis media complicated by serous labyrinthitis."</div>
                
                
                <div class="evidence-explanation">Additional case of serous labyrinthitis complicating acute otitis media with progressive vestibular dysfunction, reinforcing AOM as a causative factor.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Bacterial meningitis</div>
                
                
                <div class="item-desc">Meningogenic labyrinthitis occurs when bacteria spread from the meninges to the inner ear via the cochlear aqueduct or internal auditory canal. This is a major cause of acquired sensorineural hearing loss in children, particularly following pneumococcal meningitis.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/26536413" target="_blank">PMID:26536413</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Forty-nine patients with hearing loss from bacterial meningitis who received cochlear implants from 1991 to 2011."</div>
                
                
                <div class="evidence-explanation">Large series documenting the connection between bacterial meningitis and hearing loss requiring cochlear implantation, often via meningogenic labyrinthitis.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40225079" target="_blank">PMID:40225079</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"An 8-month-old female patient was diagnosed with meningitis, and later experienced developmental delays and hearing issues. By 4-5 years, she had complete sensorineural hearing loss in the left ear."</div>
                
                
                <div class="evidence-explanation">Case of bilateral labyrinthitis ossificans secondary to meningitis at 8 months of age, with progressive hearing loss culminating in cochlear implantation over a decade later.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Inner ear trauma</div>
                
                
                <div class="item-desc">Temporal bone fracture or surgical trauma to the inner ear can trigger labyrinthitis and subsequent labyrinthitis ossificans. Post-traumatic labyrinthitis may result in progressive sensorineural hearing loss even after the initial injury has resolved.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41146797" target="_blank">PMID:41146797</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Labyrinthitis ossificans is a rare but serious complication that can occur following inner ear trauma, often resulting in irreversible sensorineural hearing loss."</div>
                
                
                <div class="evidence-explanation">Case of a 22-year-old male who developed progressive SNHL after a motor vehicle accident, with imaging confirming post-traumatic labyrinthitis ossificans.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        

        <!-- Differential Diagnoses -->
        
        <div class="card" id="differentials">
            <div class="card-header">
                <div class="card-icon" style="background: #fef2f2; color: #dc2626;">🔀</div>
                <h2 class="card-title">Differential Diagnoses</h2>
                <span class="card-count">4</span>
            </div>
            <p style="margin-bottom: 16px; font-size: 0.95rem; color: var(--text-muted);">
                Conditions with similar clinical presentations that must be differentiated from Labyrinthitis:
            </p>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Vestibular neuritis
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0006008" target="_blank">
                            MONDO:0006008
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Acute unilateral vestibular loss causing vertigo, nystagmus, and imbalance, but sparing hearing. The key differentiating feature is the absence of sensorineural hearing loss. Vestibular neuritis preferentially affects the superior vestibular nerve, sparing the posterior canal, while labyrinthitis involves all canals more uniformly.

                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37621282" target="_blank">PMID:37621282</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Vestibular neuritis and labyrinthitis patients have different degrees and patterns of video head-impulse test involvement in the three semicircular canals, suggesting that the two distinct disorders may have different etiologies."</div>
                
                
                <div class="evidence-explanation">Study demonstrating distinct patterns of semicircular canal involvement between vestibular neuritis and labyrinthitis on video head impulse testing.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Meniere disease
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0007972" target="_blank">
                            MONDO:0007972
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Episodic vertigo with fluctuating sensorineural hearing loss, tinnitus, and aural fullness. Distinguished from labyrinthitis by its episodic recurrent nature (attacks lasting 20 minutes to 12 hours), low-frequency predominant hearing loss, and absence of infectious prodrome.

                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/23648600" target="_blank">PMID:23648600</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Common inner ear causes of vertigo include: vestibular neuritis (sudden, unilateral vestibular loss), Meniere&#39;s disease (episodic vertigo), benign paroxysmal positional vertigo (BPPV), and bilateral vestibular loss."</div>
                
                
                <div class="evidence-explanation">Review listing Meniere disease as an important differential diagnosis for inner ear vertigo, distinguished by its episodic nature.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Acoustic neuroma (vestibular schwannoma)
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0001569" target="_blank">
                            MONDO:0001569
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Benign tumor of the vestibulocochlear nerve causing progressive unilateral hearing loss, tinnitus, and vestibular symptoms. Distinguished from labyrinthitis by its insidious onset over months to years, absence of acute vertigo, and characteristic MRI findings of a cerebellopontine angle mass.

                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/23648600" target="_blank">PMID:23648600</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Common central nervous system causes of vertigo include: post concussion syndrome, cervical vertigo, vestibular migraine, cerebrovascular disease, and acoustic neuroma."</div>
                
                
                <div class="evidence-explanation">Review listing acoustic neuroma as a differential diagnosis for vertigo, distinguishable from labyrinthitis by its progressive course and MRI findings.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Central causes of acute vestibular syndrome
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Posterior circulation stroke (cerebellar or brainstem infarction) can mimic labyrinthitis with acute vertigo and hearing loss. Demyelinating diseases such as multiple sclerosis may also present as acute vestibular syndrome with hearing loss. Central causes are identified by HINTS examination findings (normal head impulse test, direction-changing nystagmus, or skew deviation) and MRI.

                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32353617" target="_blank">PMID:32353617</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Acute vestibular syndrome is most often caused by vestibular neuritis or stroke, although demyelinating diseases may be responsible for 4% of all AVS episodes."</div>
                
                
                <div class="evidence-explanation">Case report of multiple sclerosis mimicking labyrinthitis, with demyelinating lesions causing acute vestibular syndrome and hearing loss.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Datasets -->
        
        <div class="card" id="datasets">
            <div class="card-header">
                <div class="card-icon" style="background: #e0f2fe; color: #0284c7;">📊</div>
                <h2 class="card-title">Related Datasets</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box dataset-box">
                <div class="item-name">
                    Otitis Media Impact on Inner Ear
                    
                    <span class="dataset-accession">
                        <a href="#" target="_blank">GSE49122</a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Microarray gene expression profiling comparing inner ear tissue from untreated control mice and mice receiving trans-tympanic injection of heat-killed Hemophilus influenzae. Identified 886 genes with significant expression changes in the inner ear (599 upregulated, 287 downregulated), demonstrating that the inner ear mounts a distinct inflammatory response to otitis media independent of the middle ear response. Relevant to understanding the molecular mechanisms of serous labyrinthitis complicating otitis media.
</div>
                
                <div class="item-meta">
                    
                    <span class="tag tag-organism">mouse</span>
                    
                    
                    <span class="tag tag-datatype">MICROARRAY</span>
                    
                    
                    
                </div>
                
                <div class="item-meta" style="margin-top: 6px;">
                    
                    <span class="tag tag-cell">
                        Inner ear tissue
                        
                    </span>
                    
                </div>
                
                
                <div class="item-meta" style="margin-top: 6px;">
                    <strong style="font-size: 0.8rem; color: #0369a1;">Conditions:</strong>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">Otitis media</span>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">Inner ear inflammation</span>
                    
                </div>
                
                
                
    
    
                
                
                
    
    
            </div>
            
            <div class="item-box dataset-box">
                <div class="item-name">
                    Single-cell RNA-seq of endothelial and pericyte populations in the mouse cochlear stria vascularis
                    
                    <span class="dataset-accession">
                        <a href="#" target="_blank">GSE312224</a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Single-cell RNA sequencing characterizing transcriptional heterogeneity of endothelial cells and pericytes in the cochlear stria vascularis using Tie2-GFP and NG2-DsRed reporter mice. Relevant to understanding blood-labyrinth barrier biology and its disruption during labyrinthitis, a key pathophysiological mechanism involving pericyte and endothelial dysfunction.
</div>
                
                <div class="item-meta">
                    
                    <span class="tag tag-organism">mouse</span>
                    
                    
                    <span class="tag tag-datatype">SINGLE CELL RNA SEQ</span>
                    
                    
                    
                </div>
                
                <div class="item-meta" style="margin-top: 6px;">
                    
                    <span class="tag tag-cell">
                        Endothelial cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000115" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-cell">
                        Pericyte
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000669" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
                <div class="item-meta" style="margin-top: 6px;">
                    <strong style="font-size: 0.8rem; color: #0369a1;">Conditions:</strong>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">Blood-labyrinth barrier</span>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">Stria vascularis</span>
                    
                </div>
                
                
                
    
    
                
                
                
    
    
            </div>
            
            <div class="item-box dataset-box">
                <div class="item-name">
                    Ototoxicity-induced c-Fos activation underlies regenerative capacity in vestibular sensory epithelia
                    
                    <span class="dataset-accession">
                        <a href="#" target="_blank">GSE295480</a>
                    </span>
                    
                </div>
                
                <div class="item-desc">RNA sequencing of neonatal mouse utricle vestibular sensory epithelia examining the role of c-Fos activation in vestibular hair cell regeneration following gentamicin-induced ototoxic injury. Relevant to understanding regenerative potential in vestibular damage as occurs in labyrinthitis.
</div>
                
                <div class="item-meta">
                    
                    <span class="tag tag-organism">mouse</span>
                    
                    
                    <span class="tag tag-datatype">BULK RNA SEQ</span>
                    
                    
                    
                </div>
                
                <div class="item-meta" style="margin-top: 6px;">
                    
                    <span class="tag tag-cell">
                        Vestibular hair cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000609" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
                <div class="item-meta" style="margin-top: 6px;">
                    <strong style="font-size: 0.8rem; color: #0369a1;">Conditions:</strong>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">Ototoxic vestibular injury</span>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">Hair cell regeneration</span>
                    
                </div>
                
                
                
    
    
                
                
                
    
    
            </div>
            
        </div>
        

        <!-- Clinical Trials -->
        
        <div class="card" id="trials">
            <div class="card-header">
                <div class="card-icon" style="background: #f5f3ff; color: #a855f7;">🔬</div>
                <h2 class="card-title">Clinical Trials</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box clinical-trial-box">
                <div class="item-name">
                    NCT05024448
                    
                    <span class="tag tag-phase">PHASE_IV</span>
                    
                    
                    <span class="tag tag-status">COMPLETED</span>
                    
                </div>
                
                <div class="item-desc">Multicentric, randomized, double-blind, placebo-controlled study evaluating whether a 10-day course of oral corticosteroids improves vestibular recovery in acute unilateral vestibulopathy. Primary endpoint is reduction in caloric response asymmetry at 1 year; secondary endpoint is reduction in Dizziness Handicap Inventory score.
</div>
                
                
                <div class="item-meta">
                    <strong style="font-size: 0.8rem; color: #6b21a8;">Target Phenotypes:</strong>
                    
                    <span class="tag" style="background: #ede9fe; color: #6b21a8; font-size: 0.8rem;">
                        Vertigo
                        
                        <a href="http://purl.obolibrary.org/obo/HP_0002321" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                    <span class="tag" style="background: #ede9fe; color: #6b21a8; font-size: 0.8rem;">
                        Gait imbalance
                        
                        <a href="http://purl.obolibrary.org/obo/HP_0002141" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://clinicaltrials.gov/study/NCT05024448" target="_blank">clinicaltrials:NCT05024448</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The aim of this study is to demonstrate the benefit of a 10-day course of oral corticosteroids."</div>
                
                
                <div class="evidence-explanation">Phase IV RCT directly testing corticosteroid treatment for acute vestibulopathy, the condition category encompassing viral labyrinthitis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box clinical-trial-box">
                <div class="item-name">
                    NCT00335920
                    
                    <span class="tag tag-phase">PHASE_III</span>
                    
                    
                    <span class="tag tag-status">COMPLETED</span>
                    
                </div>
                
                <div class="item-desc">Prospective, randomized, double-blind, placebo-controlled multicenter study evaluating the safety and efficacy of continuous intratympanic dexamethasone infusion via temporarily implanted catheter in patients with severe to profound idiopathic sudden sensorineural hearing loss after insufficient recovery from systemic prednisolone.
</div>
                
                
                <div class="item-meta">
                    <strong style="font-size: 0.8rem; color: #6b21a8;">Target Phenotypes:</strong>
                    
                    <span class="tag" style="background: #ede9fe; color: #6b21a8; font-size: 0.8rem;">
                        Sensorineural hearing impairment
                        
                        <a href="http://purl.obolibrary.org/obo/HP_0000407" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://clinicaltrials.gov/study/NCT00335920" target="_blank">clinicaltrials:NCT00335920</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The purpose of this study is to evaluate the efficacy and safety of an intratympanic continuous two-week application of dexamethasone compared to placebo using a temporarily implanted catheter in patients with severe to profound sudden sensorineural hearing loss and insufficient recovery after..."</div>
                
                
                <div class="evidence-explanation">Phase III trial evaluating intratympanic corticosteroid delivery for sudden SNHL, a treatment approach applicable to labyrinthitis-associated hearing loss when systemic therapy fails.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box clinical-trial-box">
                <div class="item-name">
                    NCT01231009
                    
                    <span class="tag tag-phase">PHASE_I</span>
                    
                    
                    <span class="tag tag-status">RECRUITING</span>
                    
                </div>
                
                <div class="item-desc">Prospective randomized controlled clinical trial evaluating whether corticosteroids and vestibular exercises are equally effective in promoting balance recovery in patients with acute vestibular neuritis, directly relevant to treatment strategies for labyrinthitis.
</div>
                
                
                <div class="item-meta">
                    <strong style="font-size: 0.8rem; color: #6b21a8;">Target Phenotypes:</strong>
                    
                    <span class="tag" style="background: #ede9fe; color: #6b21a8; font-size: 0.8rem;">
                        Vertigo
                        
                        <a href="http://purl.obolibrary.org/obo/HP_0002321" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                    <span class="tag" style="background: #ede9fe; color: #6b21a8; font-size: 0.8rem;">
                        Gait imbalance
                        
                        <a href="http://purl.obolibrary.org/obo/HP_0002141" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://clinicaltrials.gov/study/NCT01231009" target="_blank">clinicaltrials:NCT01231009</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Aim of present study is to determine whether corticosteroids and vestibular exercises are equal effective in the recovery of balance in patients with acute vestibular neuritis."</div>
                
                
                <div class="evidence-explanation">Trial comparing corticosteroids versus vestibular exercises for acute vestibular dysfunction, findings applicable to labyrinthitis management.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Labyrinthitis
creation_date: &#39;2026-02-08T18:27:49Z&#39;
updated_date: &#39;2026-02-10T19:31:11Z&#39;
category: Complex
disease_term:
  preferred_term: labyrinthitis
  term:
    id: MONDO:0002008
    label: labyrinthitis
parents:
- Inner ear disorders
- Inflammatory diseases
has_subtypes:
- name: Viral labyrinthitis
  description: &gt;
    Most common form, often following an upper respiratory tract infection.
    Caused by viral infection of the labyrinth, most commonly by herpes
    simplex virus, adenovirus, or influenza viruses.
  subtype_term:
    preferred_term: viral labyrinthitis
    term:
      id: MONDO:0001507
      label: viral labyrinthitis
  evidence:
  - reference: PMID:40225079
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;An 8-month-old female patient was diagnosed with meningitis, and later experienced developmental delays and hearing issues.&#34;
    explanation: Case of bilateral labyrinthitis secondary to meningitis with fluctuating cochlear and vestibular symptoms over more than a decade, illustrating the long-term consequences of infectious labyrinthitis.
- name: Bacterial (suppurative) labyrinthitis
  description: &gt;
    Bacterial infection of the inner ear, typically as a complication of
    otitis media or meningitis. May cause permanent hearing loss and
    vestibular damage. Can be serous (toxin-mediated) or suppurative
    (direct bacterial invasion).
  subtype_term:
    preferred_term: purulent labyrinthitis
    term:
      id: MONDO:0001739
      label: purulent labyrinthitis
  evidence:
  - reference: PMID:41158321
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Labyrinthitis ossificans (LO) is a rare pathological ossification of the membranous labyrinth, typically arising after inflammatory or infectious insults to the inner ear.&#34;
    explanation: Case of advanced labyrinthitis ossificans resulting from recurrent childhood ear infections, demonstrating the progression from bacterial labyrinthitis to end-stage ossification.
- name: Serous labyrinthitis
  description: &gt;
    Inflammation of the inner ear caused by bacterial toxins or
    inflammatory mediators crossing the round window membrane, without
    direct bacterial invasion of the labyrinth. Often occurs as a
    complication of acute or chronic otitis media.
  subtype_term:
    preferred_term: serous labyrinthitis
    term:
      id: MONDO:0002006
      label: serous labyrinthitis
  evidence:
  - reference: PMID:41310738
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;A 34-year-old female patient of Chinese ethnicity presented with progressive vestibular dysfunction and unilateral acute otitis media complicated by serous labyrinthitis.&#34;
    explanation: Case documenting serous labyrinthitis complicating acute otitis media, with progressive vestibular dysfunction as a key feature.
pathophysiology:
- name: Pathogen entry into the inner ear
  description: &gt;
    Infectious agents reach the labyrinth through three main routes:
    (1) tympanogenic spread from the middle ear, where bacterial toxins
    or organisms cross the round or oval window membrane during otitis
    media; (2) meningitic spread via the cochlear aqueduct during
    bacterial meningitis; and (3) hematogenous or neurogenic spread,
    particularly for viral agents such as herpes simplex virus. In
    serous labyrinthitis, only toxins and inflammatory mediators cross
    the round window membrane without direct bacterial invasion,
    producing reversible dysfunction. In suppurative labyrinthitis,
    bacteria directly invade the perilymphatic space, causing severe
    purulent inflammation.
  downstream:
  - target: Innate immune activation and cytokine release
  locations:
  - preferred_term: Round window of inner ear
    term:
      id: UBERON:0002502
      label: round window of inner ear
  - preferred_term: Membranous labyrinth
    term:
      id: UBERON:0001849
      label: membranous labyrinth
  evidence:
  - reference: PMID:41310738
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;The differential impacts of toxic versus inflammatory mediators on inner ear physiology may render early combination therapy with antibiotics and glucocorticoids particularly efficacious.&#34;
    explanation: Case of serous labyrinthitis complicating AOM documenting the tympanogenic route where toxic and inflammatory mediators cross from the middle ear into the inner ear.
  - reference: PMID:39540706
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Bacterial labyrinthitis has been rarely described. Pseudomonas incrimination is even exceptional.&#34;
    explanation: Case of direct bacterial invasion of the labyrinth from acute otitis media, demonstrating the suppurative tympanogenic route of pathogen entry.
  - reference: PMID:38472515
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: &#34;We induced pneumococcal meningitis in approximately 500 C57Bl6 adult mice using live Streptococcus pneumoniae (serotype 3, 1 × 105 colony forming units (cfu) in 10 µl) injected directly into the cisterna magna of anesthetized mice&#34;
    explanation: Mouse model of pneumococcal meningitis demonstrating the meningitic route of labyrinthine infection via CSF-inner ear communication pathways.
- name: Innate immune activation and cytokine release
  description: &gt;
    Following pathogen entry, resident macrophages in the labyrinth
    transition to proinflammatory states and secrete tumor necrosis
    factor-alpha (TNF-alpha), interleukin-1 beta (IL-1beta), and
    interleukin-6 (IL-6). These cytokines drive endothelial activation
    and initiate the inflammatory cascade. In viral labyrinthitis, the
    NLRP3 inflammasome is activated, promoting IL-1beta maturation
    through caspase-1 and triggering reactive oxygen species production,
    which contributes to oxidative stress in cochlear and vestibular
    structures.
  downstream:
  - target: Leukocyte recruitment and infiltration
  - target: Blood-labyrinth barrier disruption
  cell_types:
  - preferred_term: Macrophage
    term:
      id: CL:0000235
      label: macrophage
  biological_processes:
  - preferred_term: Innate immune response
    term:
      id: GO:0045087
      label: innate immune response
    modifier: ABNORMAL
  - preferred_term: Cytokine production
    term:
      id: GO:0001816
      label: cytokine production
    modifier: ABNORMAL
  evidence:
  - reference: PMID:38472515
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: &#34;The inflammatory response to bacterial meningitis is robust and can affect all three scalae.&#34;
    explanation: Mouse meningitis model demonstrating that the innate immune response to bacterial infection involves all three cochlear scalae, reflecting widespread immune activation throughout the labyrinth.
- name: Leukocyte recruitment and infiltration
  description: &gt;
    Cytokine and chemokine signaling drives sequential recruitment of
    leukocytes into the perilymphatic spaces. Neutrophils are the first
    to arrive, peaking at approximately day 1. CCR2-positive monocytes
    and macrophages follow, with CX3CR1-positive resident macrophages
    also expanding. Lymphocytes increase subacutely by days 4-7, and
    the myeloid infiltrate peaks around day 14 in experimental models.
    Both CCR2 and CX3CR1 chemokine receptor pathways modulate the
    severity of cochlear inflammation and subsequent tissue remodeling.
  downstream:
  - target: Vestibular neuroepithelial damage
  - target: Cochlear hair cell injury
  - target: Fibroblast proliferation in the labyrinth
  locations:
  - preferred_term: Scala tympani
    term:
      id: UBERON:0001864
      label: scala tympani
  cell_types:
  - preferred_term: Neutrophil
    term:
      id: CL:0000775
      label: neutrophil
  - preferred_term: Macrophage
    term:
      id: CL:0000235
      label: macrophage
  biological_processes:
  - preferred_term: Leukocyte migration
    term:
      id: GO:0050900
      label: leukocyte migration
    modifier: ABNORMAL
  evidence:
  - reference: PMID:38472515
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: &#34;Both CCR2 and CX3CR1 monocytes and macrophages were present in the cochlea in large numbers after infection.&#34;
    explanation: Mouse meningitis model showing robust recruitment of CCR2 and CX3CR1 mononuclear phagocytes into the cochlea, with CCR2 knockout mice experiencing more severe hearing loss and ossification, indicating a protective role for innate immune trafficking.
- name: Blood-labyrinth barrier disruption
  description: &gt;
    The blood-labyrinth barrier (BLB), a specialized non-fenestrated
    microvascular barrier of the stria vascularis and cochlear
    capillaries, is disrupted by the inflammatory response. Pericyte
    and endothelial cell dysfunction under inflammatory and oxidative
    stress increases permeability, permitting serum proteins and
    leukocytes into cochlear fluids. In experimental meningitis,
    barrier disruption is detectable by 3 days post-infection and
    may restore by 7 days, but the transient breach amplifies
    inflammatory injury and impairs strial ion homeostasis.
  downstream:
  - target: Cochlear hair cell injury
  - target: Endolymphatic hydrops
  locations:
  - preferred_term: Stria vascularis of cochlear duct
    term:
      id: UBERON:0002282
      label: stria vascularis of cochlear duct
  cell_types:
  - preferred_term: Pericyte
    term:
      id: CL:0000669
      label: pericyte
  - preferred_term: Endothelial cell
    term:
      id: CL:0000115
      label: endothelial cell
  biological_processes:
  - preferred_term: Regulation of vascular permeability
    term:
      id: GO:0043114
      label: regulation of vascular permeability
    modifier: ABNORMAL
  evidence:
  - reference: PMID:38472515
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: &#34;The blood-perilymph barrier was disrupted at 3 days post infection (DPI) and was restored by seven DPI.&#34;
    explanation: Mouse meningitis model quantifying the temporal dynamics of blood-labyrinth barrier disruption, with breach at 3 days and restoration by 7 days post-infection.
  - reference: DOI:10.3390/biology13100802
    supports: SUPPORT
    evidence_source: OTHER
    snippet: &#34;pericytes, a type of vascular mural cell specialized to maintain the integrity and function of the microvasculature, may play a crucial role in the development and progression of inner ear disorders&#34;
    explanation: Review detailing how pericyte dysfunction contributes to blood-labyrinth barrier breakdown, increased permeability, and impaired neurovascular coupling in inner ear disorders.
- name: Vestibular neuroepithelial damage
  description: &gt;
    Inflammatory mediators, leukocyte infiltration, and oxidative stress
    damage the vestibular sensory epithelium. Hair cells in the cristae
    ampullares and maculae undergo injury and apoptosis, producing acute
    unilateral vestibular loss. The resulting vestibular tone asymmetry
    generates the characteristic acute vestibular syndrome with severe
    vertigo, spontaneous nystagmus, and postural imbalance.
  locations:
  - preferred_term: Vestibular labyrinth
    term:
      id: UBERON:0001862
      label: vestibular labyrinth
  cell_types:
  - preferred_term: Vestibular hair cell
    term:
      id: CL:0000609
      label: vestibular hair cell
  biological_processes:
  - preferred_term: Inflammatory response
    term:
      id: GO:0006954
      label: inflammatory response
    modifier: ABNORMAL
  evidence:
  - reference: PMID:37621282
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;In the labyrinthitis group, the mean vestibulo-ocular reflex gain was 0.72 in the ipsilesional horizontal canal, 0.73 in the ipsilesional anterior canal, and 0.55 in the ipsilesional posterior canal.&#34;
    explanation: Study of 27 labyrinthitis patients demonstrating vestibular dysfunction across all three semicircular canals, with posterior canal most severely affected.
- name: Cochlear hair cell injury
  description: &gt;
    Inflammatory mediators, leukocyte infiltration, and oxidative stress
    damage hair cells in the organ of Corti. Both inner and outer hair
    cells undergo apoptosis, and ribbon synapses between inner hair cells
    and spiral ganglion neuron dendrites are disrupted, producing
    sensorineural hearing loss. Damage to the stria vascularis disrupts
    the endocochlear potential required for hair cell mechanotransduction,
    further impairing auditory function. Cochlear involvement
    distinguishes labyrinthitis from vestibular neuritis, which spares
    hearing.
  downstream:
  - target: Spiral ganglion neuron degeneration
  locations:
  - preferred_term: Spiral organ of cochlea
    term:
      id: UBERON:0002227
      label: spiral organ of cochlea
  cell_types:
  - preferred_term: Auditory hair cell
    term:
      id: CL:0000202
      label: auditory hair cell
  biological_processes:
  - preferred_term: Apoptotic process
    term:
      id: GO:0006915
      label: apoptotic process
    modifier: ABNORMAL
  - preferred_term: Sensory perception of sound
    term:
      id: GO:0007605
      label: sensory perception of sound
    modifier: ABNORMAL
  evidence:
  - reference: PMID:27435969
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;74 % of subjects with vertigo and SSNHL demonstrated impairment of the posterior canal gain (0.45 ± 0.20).&#34;
    explanation: Study of 27 patients with vertigo and sudden sensorineural hearing loss showing combined cochlear and vestibular involvement, with 23 diagnosed as labyrinthitis.
  - reference: DOI:10.3390/biology13100802
    supports: SUPPORT
    evidence_source: OTHER
    snippet: &#34;pericytes, a type of vascular mural cell specialized to maintain the integrity and function of the microvasculature, may play a crucial role in the development and progression of inner ear disorders&#34;
    explanation: Review highlighting pericyte dysfunction in the stria vascularis as contributing to blood-labyrinth barrier breakdown and cochlear injury in inner ear inflammatory disorders.
- name: Spiral ganglion neuron degeneration
  description: &gt;
    Spiral ganglion neurons in Rosenthal&#39;s canal degenerate as a
    consequence of direct inflammatory damage, loss of neurotrophic
    support from damaged hair cells, and disruption of the cochlear
    microenvironment. Spiral ganglion neuron loss is a major determinant
    of permanent sensorineural hearing loss and limits the efficacy of
    cochlear implantation, as the implant relies on surviving neurons
    for electrical stimulation.
  locations:
  - preferred_term: Cochlea
    term:
      id: UBERON:0001844
      label: cochlea
  cell_types:
  - preferred_term: Spiral ganglion neuron
    term:
      id: CL:0011113
      label: spiral ganglion neuron
  biological_processes:
  - preferred_term: Neuron apoptotic process
    term:
      id: GO:0051402
      label: neuron apoptotic process
    modifier: ABNORMAL
  evidence:
  - reference: PMID:38472515
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: &#34;Loss of spiral ganglion neurons was common, and inner ear anatomy was distorted by scarring caused by new soft tissue and bone deposited within the scalae.&#34;
    explanation: Mouse meningitis model documenting spiral ganglion neuron loss as a common consequence of meningitic labyrinthitis, with distortion of cochlear architecture.
- name: Endolymphatic hydrops
  description: &gt;
    Post-inflammatory disruption of endolymph homeostasis can lead to
    endolymphatic hydrops. Damage to the stria vascularis impairs
    potassium recycling and the endocochlear potential, while injury
    to the endolymphatic sac or duct reduces endolymph reabsorption.
    The resulting fluid accumulation contributes to fluctuating hearing
    loss, tinnitus, and episodic vertigo in some patients during
    recovery or as a long-term sequela.
  evidence:
  - reference: PMID:28306649
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Recent investigation of secondary endolymphatic hydrops has brought attention to traumatic and inflammatory insults as causes for secondary endolymphatic hydrops.&#34;
    explanation: Review establishing inflammatory insults as a recognized cause of secondary endolymphatic hydrops, supporting the post-labyrinthitis mechanism.
- name: Autoimmune-mediated inner ear damage
  description: &gt;
    In some cases, the initial infectious trigger provokes an autoimmune
    response against inner ear antigens, perpetuating inflammation beyond
    the acute infection. Cross-reactive antibodies against inner ear
    proteins (including cochlin and heat shock proteins) and T cell-
    mediated inflammation may drive ongoing damage. This mechanism
    may explain bilateral, relapsing, or progressively worsening
    presentations that continue after clearance of the initial pathogen.
  downstream:
  - target: Cochlear hair cell injury
  - target: Vestibular neuroepithelial damage
  locations:
  - preferred_term: Internal ear
    term:
      id: UBERON:0001846
      label: internal ear
  biological_processes:
  - preferred_term: Immune response
    term:
      id: GO:0006955
      label: immune response
    modifier: ABNORMAL
  evidence:
  - reference: DOI:10.37349/ei.2024.00129
    supports: SUPPORT
    evidence_source: OTHER
    snippet: &#34;Various autoimmune disorders, including systemic lupus erythematosus, rheumatoid arthritis, and Sjogren&#39;s syndrome, have been implicated in immune-mediated damage to auditory structures, resulting in inner ear dysfunction.&#34;
    explanation: Review documenting immune-mediated mechanisms of inner ear damage, including autoantibody-mediated and T cell-mediated inflammation affecting auditory structures.
  - reference: DOI:10.1097/md.0000000000033889
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Autoimmune inner ear disease typically presents with bilateral hearing loss that progresses over weeks or months though its mechanisms are unknown. Corticosteroids are the first-line treatment, but their responses are variable and relapses are frequent.&#34;
    explanation: Case report and review documenting the relapsing nature of autoimmune inner ear disease and partial corticosteroid responsiveness.
- name: Fibroblast proliferation in the labyrinth
  description: &gt;
    Following acute inflammation, fibroblasts proliferate within the
    perilymphatic spaces of the labyrinth. Inflammatory cytokines
    and growth factors released during the immune response stimulate
    fibroblast activation and expansion. The severity of fibroblast
    proliferation is modulated by chemokine-controlled myeloid cell
    trafficking, particularly through CCR2 and CX3CR1 pathways.
  downstream:
  - target: Labyrinthine fibrosis
  locations:
  - preferred_term: Scala tympani
    term:
      id: UBERON:0001864
      label: scala tympani
  cell_types:
  - preferred_term: Fibroblast
    term:
      id: CL:0000057
      label: fibroblast
  biological_processes:
  - preferred_term: Fibroblast proliferation
    term:
      id: GO:0048144
      label: fibroblast proliferation
    modifier: ABNORMAL
  evidence:
  - reference: PMID:38472515
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: &#34;Cochlear fibrosis could be detected within 4 days of infection, and neo-ossification by 14 days.&#34;
    explanation: Mouse meningitis model showing fibroblast-driven tissue remodeling as the earliest reparative response, detectable within 4 days post-infection.
- name: Labyrinthine fibrosis
  description: &gt;
    Activated fibroblasts deposit extracellular matrix proteins
    including collagen within the perilymphatic spaces, producing
    fibrotic tissue that replaces normal labyrinthine structures.
    Fibrosis is most prominent in the scala tympani basal turn and
    distorts inner ear architecture, contributing to permanent
    sensorineural hearing loss. This fibrous stage precedes and
    provides the scaffold for subsequent neo-ossification.
  downstream:
  - target: Labyrinthitis ossificans
  locations:
  - preferred_term: Scala tympani
    term:
      id: UBERON:0001864
      label: scala tympani
  biological_processes:
  - preferred_term: Extracellular matrix organization
    term:
      id: GO:0030198
      label: extracellular matrix organization
    modifier: ABNORMAL
  evidence:
  - reference: PMID:38472515
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: &#34;inner ear anatomy was distorted by scarring caused by new soft tissue and bone deposited within the scalae.&#34;
    explanation: Mouse meningitis model documenting distortion of inner ear architecture by fibrotic soft tissue deposited within the cochlear scalae.
- name: Labyrinthitis ossificans
  description: &gt;
    In the most severe cases, labyrinthine fibrosis progresses to
    neo-ossification, with new bone formation visible by 14 days
    post-infection. Osteoblast-like cells deposit mineralized tissue
    within the perilymphatic spaces, progressively obliterating the
    cochlear lumen. This labyrinthitis ossificans is most prominent
    in the scala tympani basal turn and causes permanent profound
    sensorineural hearing loss. The obliteration of cochlear
    architecture can prevent or severely complicate cochlear
    implantation, making early diagnosis and intervention critical.
  locations:
  - preferred_term: Scala tympani
    term:
      id: UBERON:0001864
      label: scala tympani
  - preferred_term: Membranous labyrinth
    term:
      id: UBERON:0001849
      label: membranous labyrinth
  biological_processes:
  - preferred_term: Ossification
    term:
      id: GO:0001503
      label: ossification
    modifier: ABNORMAL
  evidence:
  - reference: PMID:39670911
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Labyrinthitis ossificans is a pathology consisting of calcification of the membranous labyrinth resulting in profound sensory deafness. It is usually due to an acute inflammatory process that progresses to ossification of the labyrinth.&#34;
    explanation: Review establishing that labyrinthitis leads to labyrinthitis ossificans through progressive calcification of the membranous labyrinth.
  - reference: PMID:38472515
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: &#34;Cochlear fibrosis could be detected within 4 days of infection, and neo-ossification by 14 days.&#34;
    explanation: Mouse meningitis model documenting neo-ossification visible by 14 days post-infection as the terminal stage of post-inflammatory cochlear remodeling.
progression:
- phase: Acute phase
  notes: &gt;
    Onset within hours to days of the triggering event. Characterized by
    severe vertigo, nausea, vomiting, spontaneous nystagmus, and
    sensorineural hearing loss. The vertigo is most intense in the first
    24-72 hours. Leukocyte infiltration begins with neutrophils peaking
    at approximately day 1, followed by monocytes/macrophages and
    lymphocytes rising by days 4-7.
  evidence:
  - reference: PMID:14977076
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;two common labyrinthine diseases that provoke severe attacks of vertigo with spontaneous nystagmus: vestibular neuritis (vestibular loss alone) and viral labyrinthitis (cochleovestibular loss).&#34;
    explanation: Study documenting the acute presentation of viral labyrinthitis with severe vertigo and spontaneous nystagmus.
- phase: Recovery and compensation
  notes: &gt;
    Over weeks to months, central vestibular compensation reduces vertigo.
    Hearing may partially recover in viral forms, particularly with early
    corticosteroid treatment. Vestibular rehabilitation accelerates
    compensation. Some patients develop secondary endolymphatic hydrops
    with fluctuating symptoms.
  evidence:
  - reference: DOI:10.1136/bcr-2023-258290
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Symptoms improved gradually with steroids and vestibular rehabilitation therapy. However, the long-term repercussions of post-COVID-19 acute labyrinthitis are unknown and must be followed up closely.&#34;
    explanation: Case demonstrating gradual recovery with treatment but uncertainty about long-term outcomes.
- phase: Chronic sequelae
  notes: &gt;
    In severe cases, particularly suppurative labyrinthitis, permanent
    sensorineural hearing loss and chronic vestibular hypofunction may
    result. Labyrinthitis ossificans can develop within weeks to months,
    with fibrosis appearing as early as 4 days and ossification by 14-30
    days post-infection in animal models. This progressive calcification
    of the membranous labyrinth complicates cochlear implantation.
  evidence:
  - reference: PMID:39670911
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Labyrinthitis ossificans is a pathology consisting of calcification of the membranous labyrinth resulting in profound sensory deafness. It is usually due to an acute inflammatory process that progresses to ossification of the labyrinth.&#34;
    explanation: Review documenting labyrinthitis ossificans as a chronic sequela of labyrinthitis causing irreversible profound deafness.
  - reference: PMID:26536413
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Nineteen (48.7%) patients had intraoperative evidence of LO.&#34;
    explanation: Nearly half of children requiring cochlear implantation after meningitis had labyrinthitis ossificans, demonstrating the frequency of this chronic sequela.
  - reference: PMID:40225079
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Labyrinthitis ossificans (LO) is the end stage of labyrinthitis. Existing case reports primarily center around hearing loss and overlook a crucial aspect that patients with LO frequently experience balance problems, while our study fills this gap.&#34;
    explanation: Case of bilateral LO with fluctuating cochlear and vestibular symptoms persisting over more than a decade, highlighting both hearing and balance consequences as chronic sequelae.
  - reference: PMID:41146797
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Labyrinthitis ossificans is a rare but serious complication that can occur following inner ear trauma, often resulting in irreversible sensorineural hearing loss.&#34;
    explanation: Case of post-traumatic labyrinthitis ossificans demonstrating that trauma, not only infection, can trigger the ossification pathway as a chronic sequela.
phenotypes:
- name: Vertigo
  description: &gt;
    Acute onset of severe rotational vertigo lasting days to weeks, often
    accompanied by nausea and vomiting. The vertigo results from sudden
    unilateral vestibular loss creating an asymmetry in tonic vestibular
    input. Typically most severe in the first 24-72 hours with gradual
    improvement over weeks as central vestibular compensation occurs.
  frequency: OBLIGATE
  phenotype_term:
    preferred_term: Vertigo
    term:
      id: HP:0002321
      label: Vertigo
  evidence:
  - reference: PMID:14977076
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;To evaluate the dynamic properties of the horizontal vestibulo-ocular reflex (h-VOR) in the acute stage of two common labyrinthine diseases that provoke severe attacks of vertigo with spontaneous nystagmus: vestibular neuritis (vestibular loss alone) and viral labyrinthitis (cochleovestibular loss).&#34;
    explanation: Study of 21 viral labyrinthitis patients documenting severe vertigo with spontaneous nystagmus as a cardinal feature.
- name: Sensorineural hearing loss
  description: &gt;
    Unilateral sensorineural hearing loss distinguishing labyrinthitis
    from vestibular neuritis. May range from mild high-frequency loss to
    profound deafness. Hearing loss may be transient in serous forms but
    is often permanent in suppurative labyrinthitis.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  evidence:
  - reference: PMID:37621282
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;pure-tone audiometry, ipsilesional posterior canal gain, and gain asymmetry of posterior canal were excellent parameters for distinguishing labyrinthitis from vestibular neuritis.&#34;
    explanation: Study demonstrating that sensorineural hearing loss on audiometry is the key distinguishing feature between labyrinthitis and vestibular neuritis.
  - reference: PMID:39540706
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;A tonal audiogram showed a left perceptive deafness.&#34;
    explanation: Case of bacterial labyrinthitis documenting sensorineural hearing loss confirmed on audiometry, with deafness persisting despite treatment.
- name: Tinnitus
  description: &gt;
    Ringing, buzzing, or roaring sensation in the affected ear,
    accompanying cochlear involvement. May persist after resolution
    of acute vertigo.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Tinnitus
    term:
      id: HP:0000360
      label: Tinnitus
  evidence:
  - reference: PMID:39540706
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;A 18-year-old female presented with left sudden hearing loss, rotatory vertigo, vomiting, and tinnitus evolving for 24 hours.&#34;
    explanation: Case of bacterial labyrinthitis presenting with tinnitus as part of the acute symptom complex.
- name: Nystagmus
  description: &gt;
    Spontaneous horizontal or horizontal-rotatory nystagmus beating away
    from the affected ear during the acute phase, reflecting the vestibular
    tone asymmetry. Direction-fixed and suppressed by visual fixation
    (peripheral pattern). May reverse direction during recovery as
    central compensation overshoots.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Nystagmus
    term:
      id: HP:0000639
      label: Nystagmus
  evidence:
  - reference: PMID:14977076
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;two common labyrinthine diseases that provoke severe attacks of vertigo with spontaneous nystagmus: vestibular neuritis (vestibular loss alone) and viral labyrinthitis (cochleovestibular loss).&#34;
    explanation: Study documenting spontaneous nystagmus as a defining feature of both vestibular neuritis and viral labyrinthitis.
- name: Nausea and vomiting
  description: &gt;
    Severe nausea and vomiting during the acute phase due to vestibular
    autonomic reflexes triggered by the sudden vestibular asymmetry.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Nausea and vomiting
    term:
      id: HP:0002017
      label: Nausea and vomiting
  evidence:
  - reference: PMID:39670911
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;The clinical manifestations are irreversible hearing loss, dizziness and vomiting.&#34;
    explanation: Review listing vomiting as one of the cardinal clinical manifestations of labyrinthitis ossificans, reflecting the vestibular component of labyrinthitis.
  - reference: PMID:39540706
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;A 18-year-old female presented with left sudden hearing loss, rotatory vertigo, vomiting, and tinnitus evolving for 24 hours.&#34;
    explanation: Case of bacterial labyrinthitis documenting vomiting as a presenting symptom alongside vertigo, hearing loss, and tinnitus.
- name: Postural imbalance
  description: &gt;
    Unsteadiness and difficulty walking, particularly with eyes closed
    or in darkness, persisting for weeks to months after acute vertigo
    resolves as central vestibular compensation develops.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Gait imbalance
    term:
      id: HP:0002141
      label: Gait imbalance
  evidence:
  - reference: DOI:10.1136/bcr-2023-258290
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;We report on a boy in his early adolescence with a sudden onset of spinning sensation, imbalance and unilateral hearing loss with a positive SARS-CoV-2 test.&#34;
    explanation: Case of COVID-19-induced labyrinthitis documenting imbalance as a presenting feature alongside vertigo and hearing loss.
  - reference: PMID:23648600
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Disorders of the inner ear can cause hearing loss, tinnitus, vertigo and imbalance.&#34;
    explanation: Review establishing imbalance as a cardinal symptom of inner ear disorders including labyrinthitis.
diagnosis:
- name: Clinical assessment (acute vestibular syndrome)
  description: &gt;
    Diagnosis is primarily clinical, based on the combination of acute
    onset vertigo, sensorineural hearing loss, and nystagmus. The
    HINTS examination (Head Impulse, Nystagmus, Test of Skew) helps
    differentiate peripheral from central causes. A positive head
    impulse test toward the affected side, direction-fixed nystagmus,
    and absent skew deviation suggest a peripheral etiology.
  evidence:
  - reference: PMID:23648600
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;The clinical pattern and duration of vertigo are the most important clinical features in the diagnosis.&#34;
    explanation: Review establishing that clinical assessment based on vertigo pattern and duration is the primary diagnostic approach for inner ear disorders including labyrinthitis.
  - reference: PMID:41310738
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Patients with vertigo and labyrinthitis secondary to acute otitis media typically exhibit variable vestibular symptoms, with unidirectional irritative nystagmus serving as a cardinal diagnostic sign.&#34;
    explanation: Case report highlighting unidirectional irritative nystagmus as a cardinal diagnostic sign for labyrinthitis complicating acute otitis media, and emphasizing integration of audiological and vestibular function assessments.
- name: Audiometry
  description: &gt;
    Pure-tone audiometry demonstrates unilateral sensorineural hearing
    loss, which is the key finding distinguishing labyrinthitis from
    vestibular neuritis. The pattern and severity of hearing loss
    help guide prognosis and management.
  diagnosis_term:
    preferred_term: audiometric testing
    term:
      id: MAXO:0000125
      label: audiometric testing
  evidence:
  - reference: PMID:37621282
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;pure-tone audiometry, ipsilesional posterior canal gain, and gain asymmetry of posterior canal were excellent parameters for distinguishing labyrinthitis from vestibular neuritis.&#34;
    explanation: Study confirming pure-tone audiometry as an excellent diagnostic parameter for distinguishing labyrinthitis from vestibular neuritis.
- name: MRI with gadolinium
  description: &gt;
    MRI with gadolinium enhancement can demonstrate labyrinthine
    enhancement indicating inflammation, and is important for
    excluding retrocochlear pathology (vestibular schwannoma) and
    central causes of acute vestibular syndrome (stroke). Enhancement
    of the labyrinth on FLAIR or T1 post-contrast sequences supports
    the diagnosis.
  diagnosis_term:
    preferred_term: magnetic resonance imaging procedure
    term:
      id: MAXO:0000424
      label: magnetic resonance imaging procedure
  evidence:
  - reference: PMID:39540706
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;constructive interference steady state (CISS) sequence revealed intense labyrinthine enhancement.&#34;
    explanation: Case demonstrating MRI labyrinthine enhancement as a diagnostic finding in bacterial labyrinthitis, also used to exclude cholesteatoma.
  - reference: PMID:39670911
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;It is diagnosed by computed tomography (CT) and magnetic resonance imaging (MRI). It is important to make the correct diagnosis before cochlear implantation, as ossification of the labyrinth can hinder or prevent the implantation of electrodes.&#34;
    explanation: Review confirming MRI as essential for diagnosing labyrinthitis ossificans and guiding cochlear implantation planning.
  - reference: PMID:41158321
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;This case illustrates how advanced LO can closely mimic congenital inner ear malformations on imaging, making accurate diagnosis particularly challenging.&#34;
    explanation: Case demonstrating the diagnostic pitfalls of advanced labyrinthitis ossificans on imaging and the necessity of combining clinical history, audiometry, and multimodal imaging.
treatments:
- name: Vestibular suppressants
  description: &gt;
    Short-term use of vestibular suppressants (benzodiazepines,
    antihistamines such as meclizine or dimenhydrinate, anticholinergics)
    to control acute vertigo, nausea, and vomiting. Should be limited
    to the first 48-72 hours to avoid delaying central vestibular
    compensation.
  context: Acute phase symptom management
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
    qualifiers:
    - predicate:
        preferred_term: therapeutic agent
        term:
          id: NCIT:C2259
          label: Therapeutic Agent
      value:
        preferred_term: meclizine
        term:
          id: NCIT:C61610
          label: Meclizine
    - predicate:
        preferred_term: therapeutic agent
        term:
          id: NCIT:C2259
          label: Therapeutic Agent
      value:
        preferred_term: dimenhydrinate
        term:
          id: NCIT:C28992
          label: Dimenhydrinate
    - predicate:
        preferred_term: therapeutic agent
        term:
          id: NCIT:C2259
          label: Therapeutic Agent
      value:
        preferred_term: diazepam
        term:
          id: NCIT:C28982
          label: Diazepam
  target_phenotypes:
  - preferred_term: Vertigo
    term:
      id: HP:0002321
      label: Vertigo
  - preferred_term: Nausea and vomiting
    term:
      id: HP:0002017
      label: Nausea and vomiting
  evidence:
  - reference: PMID:37953517
    supports: SUPPORT
    evidence_source: OTHER
    snippet: &#34;Anticholinergics, phenothiazines, antihistamines, antidopaminergics, benzodiazepines, and calcium channel antagonists are examples of vestibular suppressants.&#34;
    explanation: Review cataloging the major classes of vestibular suppressants used for symptomatic management of acute unilateral vestibulopathy.
  - reference: PMID:34411472
    supports: SUPPORT
    evidence_source: OTHER
    snippet: &#34;Symptomatic therapies include generalized supportive care and administration of vestibular suppressants and antiemetics.&#34;
    explanation: Review establishing vestibular suppressants and antiemetics as the standard symptomatic therapy for acute vestibular neuritis, applicable to labyrinthitis management.
- name: Corticosteroids
  description: &gt;
    Systemic corticosteroids (oral or intravenous) may be used in the
    acute phase to reduce inner ear inflammation and potentially improve
    hearing outcomes. Intratympanic steroid injection is an alternative
    route of administration. The evidence for efficacy is stronger for
    hearing recovery than for vestibular recovery.
  context: Acute phase anti-inflammatory therapy
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
    qualifiers:
    - predicate:
        preferred_term: therapeutic agent
        term:
          id: NCIT:C2259
          label: Therapeutic Agent
      value:
        preferred_term: prednisolone
        term:
          id: NCIT:C769
          label: Prednisolone
    - predicate:
        preferred_term: therapeutic agent
        term:
          id: NCIT:C2259
          label: Therapeutic Agent
      value:
        preferred_term: dexamethasone
        term:
          id: NCIT:C422
          label: Dexamethasone
  target_phenotypes:
  - preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  evidence:
  - reference: DOI:10.1136/bcr-2023-258290
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Symptoms improved gradually with steroids and vestibular rehabilitation therapy.&#34;
    explanation: Case of COVID-19-induced acute labyrinthitis in a teenager showing improvement with corticosteroid treatment and vestibular rehabilitation.
  - reference: DOI:10.1097/md.0000000000033889
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Corticosteroids are the first-line treatment, but their responses are variable and relapses are frequent.&#34;
    explanation: Review establishing corticosteroids as first-line therapy for autoimmune inner ear disease, though with variable responses.
  - reference: PMID:41310738
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;ceftriaxone sodium (2 g) and dexamethasone (10 mg) were administered via intravenous infusion once daily for 5 days, complemented by hydroxymethazoline and mometasone furoate nasal sprays as adjunctive antiinflammatory measures. Within a week, audiometric thresholds returned to normal, nystagmus intensity progressively diminished, and vertigo resolved entirely.&#34;
    explanation: Case demonstrating complete audiometric and vestibular recovery within one week with early combination IV dexamethasone and antibiotic therapy for serous labyrinthitis.
  - reference: PMID:40225079
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Despite the temporary effectiveness of corticosteroid treatment during the process, cochlear implantation was ultimately required.&#34;
    explanation: Case showing that while corticosteroids provided temporary improvement in labyrinthitis ossificans, they were insufficient to prevent progressive hearing loss requiring cochlear implantation.
- name: Antiviral therapy
  description: &gt;
    Antiviral medications (acyclovir, valacyclovir) may be considered
    when viral etiology is suspected, particularly herpes simplex or
    varicella-zoster virus. Often combined with corticosteroids. The
    evidence for efficacy as monotherapy is limited.
  context: Suspected viral etiology
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
    qualifiers:
    - predicate:
        preferred_term: therapeutic agent
        term:
          id: NCIT:C2259
          label: Therapeutic Agent
      value:
        preferred_term: acyclovir
        term:
          id: NCIT:C205
          label: Acyclovir
    - predicate:
        preferred_term: therapeutic agent
        term:
          id: NCIT:C2259
          label: Therapeutic Agent
      value:
        preferred_term: valacyclovir
        term:
          id: NCIT:C28235
          label: Valacyclovir
  evidence:
  - reference: PMID:15269315
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Analysis of variance showed a significant effect of methylprednisolone (P&lt;0.001) but not of valacyclovir (P=0.43). The combination of methylprednisolone and valacyclovir was not superior to corticosteroid monotherapy.&#34;
    explanation: Landmark NEJM RCT of 141 patients with acute vestibular neuritis demonstrating that valacyclovir had no significant effect on vestibular recovery, refuting antiviral efficacy for this indication.
  - reference: PMID:37953517
    supports: PARTIAL
    evidence_source: OTHER
    snippet: &#34;Antivirals are even more contentious in the context of AUV treatment.&#34;
    explanation: Review confirming that antiviral therapy remains controversial and unsupported by robust evidence for acute unilateral vestibulopathy.
- name: Antibiotics
  description: &gt;
    Systemic antibiotics are essential for bacterial labyrinthitis.
    Broad-spectrum intravenous antibiotics with good CNS and inner ear
    penetration are required. Surgical drainage may be necessary for
    suppurative labyrinthitis complicating otitis media or
    cholesteatoma.
  context: Bacterial labyrinthitis
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
    qualifiers:
    - predicate:
        preferred_term: therapeutic agent
        term:
          id: NCIT:C2259
          label: Therapeutic Agent
      value:
        preferred_term: cefotaxime
        term:
          id: NCIT:C354
          label: Cefotaxime
    - predicate:
        preferred_term: therapeutic agent
        term:
          id: NCIT:C2259
          label: Therapeutic Agent
      value:
        preferred_term: vancomycin
        term:
          id: NCIT:C925
          label: Vancomycin
  evidence:
  - reference: PMID:39540706
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;She initially received probabilistic intravenous antibiotherapy associating cefotaxime to vancomycin for 17 days, then, we switched to adapt to the antibiogram. She had a total of 25 days of antibiotic therapy and 14 days of corticosteroid treatment.&#34;
    explanation: Case demonstrating prolonged IV antibiotic therapy (25 days) required for bacterial labyrinthitis complicating otitis media.
- name: Vestibular rehabilitation therapy
  description: &gt;
    Structured exercise program to promote central vestibular
    compensation after the acute phase. Includes gaze stabilization
    exercises, habituation exercises, and balance training. Early
    initiation (once acute symptoms subside) improves outcomes.
  context: Post-acute recovery phase
  treatment_term:
    preferred_term: physical therapy
    term:
      id: MAXO:0000011
      label: physical therapy
  target_phenotypes:
  - preferred_term: Vertigo
    term:
      id: HP:0002321
      label: Vertigo
  - preferred_term: Gait imbalance
    term:
      id: HP:0002141
      label: Gait imbalance
  evidence:
  - reference: DOI:10.1136/bcr-2023-258290
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Symptoms improved gradually with steroids and vestibular rehabilitation therapy.&#34;
    explanation: Case report demonstrating improvement with vestibular rehabilitation therapy in COVID-19-induced acute labyrinthitis.
- name: Cochlear implantation
  description: &gt;
    For patients with profound sensorineural hearing loss following
    labyrinthitis, cochlear implantation may restore auditory function.
    Early implantation is important because labyrinthitis ossificans
    can obliterate the cochlear lumen, making electrode insertion
    difficult or impossible.
  context: Permanent severe to profound hearing loss
  treatment_term:
    preferred_term: implantation
    term:
      id: MAXO:0000451
      label: implantation
    qualifiers:
    - predicate:
        preferred_term: medical device
        term:
          id: NCIT:C16830
          label: Medical Device
      value:
        preferred_term: cochlear implant
        term:
          id: NCIT:C157820
          label: Cochlear Implant
  target_phenotypes:
  - preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  evidence:
  - reference: PMID:26536413
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Nineteen (48.7%) patients had intraoperative evidence of LO. Fourteen patients (70.0%) without LO compared with seven (36.8%) with LO developed open-set speech after implantation.&#34;
    explanation: Study of 39 children with post-meningitic hearing loss showing labyrinthitis ossificans negatively impacts cochlear implant outcomes.
  - reference: PMID:39670911
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;It is important to make the correct diagnosis before cochlear implantation, as ossification of the labyrinth can hinder or prevent the implantation of electrodes.&#34;
    explanation: Review emphasizing the importance of early cochlear implantation before labyrinthitis ossificans obliterates the cochlear lumen.
  - reference: PMID:41158321
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;while cochlear implantation remains feasible in early or partial ossification, advanced cases may require alternative rehabilitation strategies. Early diagnosis is crucial for optimizing hearing outcomes.&#34;
    explanation: Case of advanced LO demonstrating that cochlear implantation feasibility depends on ossification stage, with a small residual basal turn segment being the only remaining option in advanced cases.
prevalence:
- population: General population
  notes: &gt;
    Labyrinthitis is relatively uncommon compared to vestibular neuritis.
    Viral labyrinthitis is the most common form. Bacterial labyrinthitis
    has become rare in the antibiotic era but remains a serious
    complication of otitis media and meningitis, particularly in children.
    The incidence of vestibular neuritis (the closely related condition
    without hearing loss) is estimated at 3.5 per 100,000 population.
  evidence:
  - reference: PMID:39540706
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Labyrinthitis is increasingly rare in the era of antibiotic therapy.&#34;
    explanation: Case report confirming the rarity of bacterial labyrinthitis in the modern antibiotic era.
genetic:
- name: Susceptibility factors
  notes: &gt;
    Labyrinthitis is not a primarily genetic disorder. However, genetic
    variation in immune response genes (HLA alleles, cytokine
    polymorphisms) may influence susceptibility to viral or autoimmune
    labyrinthitis. Mutations affecting inner ear structural proteins
    may predispose to inflammatory damage.
  presence: UNKNOWN
environmental:
- name: Viral upper respiratory tract infection
  description: &gt;
    The most common preceding event, with viral labyrinthitis typically
    developing during or shortly after an upper respiratory tract
    infection. Viruses may reach the inner ear via hematogenous spread
    or direct extension along the cochlear nerve.
  effect: PREDISPOSING
  evidence:
  - reference: DOI:10.1136/bcr-2023-258290
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;We report COVID-19-induced acute labyrinthitis in a teenager.&#34;
    explanation: Case report documenting SARS-CoV-2 viral infection as a trigger for acute labyrinthitis, illustrating the viral etiology pathway.
- name: Otitis media
  description: &gt;
    Acute or chronic otitis media is the primary risk factor for
    serous and suppurative bacterial labyrinthitis. Bacterial toxins
    or organisms can cross the round window membrane to infect the
    inner ear. Cholesteatoma erosion into the labyrinth is another
    route of infection.
  effect: CAUSATIVE
  evidence:
  - reference: PMID:39540706
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Ten days earlier, she presented symptoms of acute media otitis.&#34;
    explanation: Case report documenting bacterial labyrinthitis developing as a complication of acute otitis media, with Pseudomonas crossing from the middle ear.
  - reference: PMID:41310738
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;A 34-year-old female patient of Chinese ethnicity presented with progressive vestibular dysfunction and unilateral acute otitis media complicated by serous labyrinthitis.&#34;
    explanation: Additional case of serous labyrinthitis complicating acute otitis media with progressive vestibular dysfunction, reinforcing AOM as a causative factor.
- name: Bacterial meningitis
  description: &gt;
    Meningogenic labyrinthitis occurs when bacteria spread from the
    meninges to the inner ear via the cochlear aqueduct or internal
    auditory canal. This is a major cause of acquired sensorineural
    hearing loss in children, particularly following pneumococcal
    meningitis.
  effect: CAUSATIVE
  evidence:
  - reference: PMID:26536413
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Forty-nine patients with hearing loss from bacterial meningitis who received cochlear implants from 1991 to 2011.&#34;
    explanation: Large series documenting the connection between bacterial meningitis and hearing loss requiring cochlear implantation, often via meningogenic labyrinthitis.
  - reference: PMID:40225079
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;An 8-month-old female patient was diagnosed with meningitis, and later experienced developmental delays and hearing issues. By 4-5 years, she had complete sensorineural hearing loss in the left ear.&#34;
    explanation: Case of bilateral labyrinthitis ossificans secondary to meningitis at 8 months of age, with progressive hearing loss culminating in cochlear implantation over a decade later.
- name: Inner ear trauma
  description: &gt;
    Temporal bone fracture or surgical trauma to the inner ear can
    trigger labyrinthitis and subsequent labyrinthitis ossificans.
    Post-traumatic labyrinthitis may result in progressive sensorineural
    hearing loss even after the initial injury has resolved.
  effect: CAUSATIVE
  evidence:
  - reference: PMID:41146797
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Labyrinthitis ossificans is a rare but serious complication that can occur following inner ear trauma, often resulting in irreversible sensorineural hearing loss.&#34;
    explanation: Case of a 22-year-old male who developed progressive SNHL after a motor vehicle accident, with imaging confirming post-traumatic labyrinthitis ossificans.
differential_diagnoses:
- name: Vestibular neuritis
  description: &gt;
    Acute unilateral vestibular loss causing vertigo, nystagmus, and
    imbalance, but sparing hearing. The key differentiating feature is
    the absence of sensorineural hearing loss. Vestibular neuritis
    preferentially affects the superior vestibular nerve, sparing the
    posterior canal, while labyrinthitis involves all canals more
    uniformly.
  disease_term:
    preferred_term: vestibular neuronitis
    term:
      id: MONDO:0006008
      label: vestibular neuronitis
  evidence:
  - reference: PMID:37621282
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Vestibular neuritis and labyrinthitis patients have different degrees and patterns of video head-impulse test involvement in the three semicircular canals, suggesting that the two distinct disorders may have different etiologies.&#34;
    explanation: Study demonstrating distinct patterns of semicircular canal involvement between vestibular neuritis and labyrinthitis on video head impulse testing.
- name: Meniere disease
  description: &gt;
    Episodic vertigo with fluctuating sensorineural hearing loss,
    tinnitus, and aural fullness. Distinguished from labyrinthitis
    by its episodic recurrent nature (attacks lasting 20 minutes to
    12 hours), low-frequency predominant hearing loss, and absence of
    infectious prodrome.
  disease_term:
    preferred_term: Meniere disease
    term:
      id: MONDO:0007972
      label: Meniere disease
  evidence:
  - reference: PMID:23648600
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Common inner ear causes of vertigo include: vestibular neuritis (sudden, unilateral vestibular loss), Meniere&#39;s disease (episodic vertigo), benign paroxysmal positional vertigo (BPPV), and bilateral vestibular loss.&#34;
    explanation: Review listing Meniere disease as an important differential diagnosis for inner ear vertigo, distinguished by its episodic nature.
- name: Acoustic neuroma (vestibular schwannoma)
  description: &gt;
    Benign tumor of the vestibulocochlear nerve causing progressive
    unilateral hearing loss, tinnitus, and vestibular symptoms.
    Distinguished from labyrinthitis by its insidious onset over months
    to years, absence of acute vertigo, and characteristic MRI findings
    of a cerebellopontine angle mass.
  disease_term:
    preferred_term: acoustic neuroma
    term:
      id: MONDO:0001569
      label: acoustic neuroma
  evidence:
  - reference: PMID:23648600
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Common central nervous system causes of vertigo include: post concussion syndrome, cervical vertigo, vestibular migraine, cerebrovascular disease, and acoustic neuroma.&#34;
    explanation: Review listing acoustic neuroma as a differential diagnosis for vertigo, distinguishable from labyrinthitis by its progressive course and MRI findings.
- name: Central causes of acute vestibular syndrome
  description: &gt;
    Posterior circulation stroke (cerebellar or brainstem infarction)
    can mimic labyrinthitis with acute vertigo and hearing loss.
    Demyelinating diseases such as multiple sclerosis may also present
    as acute vestibular syndrome with hearing loss. Central causes are
    identified by HINTS examination findings (normal head impulse test,
    direction-changing nystagmus, or skew deviation) and MRI.
  evidence:
  - reference: PMID:32353617
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Acute vestibular syndrome is most often caused by vestibular neuritis or stroke, although demyelinating diseases may be responsible for 4% of all AVS episodes.&#34;
    explanation: Case report of multiple sclerosis mimicking labyrinthitis, with demyelinating lesions causing acute vestibular syndrome and hearing loss.
clinical_trials:
- name: NCT05024448
  phase: PHASE_IV
  status: COMPLETED
  description: &gt;
    Multicentric, randomized, double-blind, placebo-controlled study evaluating
    whether a 10-day course of oral corticosteroids improves vestibular recovery
    in acute unilateral vestibulopathy. Primary endpoint is reduction in caloric
    response asymmetry at 1 year; secondary endpoint is reduction in Dizziness
    Handicap Inventory score.
  target_phenotypes:
  - preferred_term: Vertigo
    term:
      id: HP:0002321
      label: Vertigo
  - preferred_term: Gait imbalance
    term:
      id: HP:0002141
      label: Gait imbalance
  evidence:
  - reference: clinicaltrials:NCT05024448
    supports: SUPPORT
    snippet: &#34;The aim of this study is to demonstrate the benefit of a 10-day course of oral corticosteroids.&#34;
    explanation: Phase IV RCT directly testing corticosteroid treatment for acute vestibulopathy, the condition category encompassing viral labyrinthitis.
- name: NCT00335920
  phase: PHASE_III
  status: COMPLETED
  description: &gt;
    Prospective, randomized, double-blind, placebo-controlled multicenter study
    evaluating the safety and efficacy of continuous intratympanic dexamethasone
    infusion via temporarily implanted catheter in patients with severe to
    profound idiopathic sudden sensorineural hearing loss after insufficient
    recovery from systemic prednisolone.
  target_phenotypes:
  - preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  evidence:
  - reference: clinicaltrials:NCT00335920
    supports: SUPPORT
    snippet: &#34;The purpose of this study is to evaluate the efficacy and safety of an intratympanic continuous two-week application of dexamethasone compared to placebo using a temporarily implanted catheter in patients with severe to profound sudden sensorineural hearing loss and insufficient recovery after initial systemic prednisolone therapy.&#34;
    explanation: Phase III trial evaluating intratympanic corticosteroid delivery for sudden SNHL, a treatment approach applicable to labyrinthitis-associated hearing loss when systemic therapy fails.
- name: NCT01231009
  phase: PHASE_I
  status: RECRUITING
  description: &gt;
    Prospective randomized controlled clinical trial evaluating whether
    corticosteroids and vestibular exercises are equally effective in
    promoting balance recovery in patients with acute vestibular neuritis,
    directly relevant to treatment strategies for labyrinthitis.
  target_phenotypes:
  - preferred_term: Vertigo
    term:
      id: HP:0002321
      label: Vertigo
  - preferred_term: Gait imbalance
    term:
      id: HP:0002141
      label: Gait imbalance
  evidence:
  - reference: clinicaltrials:NCT01231009
    supports: SUPPORT
    snippet: &#34;Aim of present study is to determine whether corticosteroids and vestibular exercises are equal effective in the recovery of balance in patients with acute vestibular neuritis.&#34;
    explanation: Trial comparing corticosteroids versus vestibular exercises for acute vestibular dysfunction, findings applicable to labyrinthitis management.
datasets:
- accession: GSE49122
  title: Otitis Media Impact on Inner Ear
  description: &gt;
    Microarray gene expression profiling comparing inner ear tissue from
    untreated control mice and mice receiving trans-tympanic injection of
    heat-killed Hemophilus influenzae. Identified 886 genes with significant
    expression changes in the inner ear (599 upregulated, 287 downregulated),
    demonstrating that the inner ear mounts a distinct inflammatory response
    to otitis media independent of the middle ear response. Relevant to
    understanding the molecular mechanisms of serous labyrinthitis
    complicating otitis media.
  organism:
    preferred_term: mouse
    term:
      id: NCBITaxon:10090
      label: Mus musculus
  data_type: MICROARRAY
  sample_types:
  - preferred_term: Inner ear tissue
  conditions:
  - Otitis media
  - Inner ear inflammation
- accession: GSE312224
  title: Single-cell RNA-seq of endothelial and pericyte populations in the mouse cochlear stria vascularis
  description: &gt;
    Single-cell RNA sequencing characterizing transcriptional heterogeneity
    of endothelial cells and pericytes in the cochlear stria vascularis
    using Tie2-GFP and NG2-DsRed reporter mice. Relevant to understanding
    blood-labyrinth barrier biology and its disruption during labyrinthitis,
    a key pathophysiological mechanism involving pericyte and endothelial
    dysfunction.
  organism:
    preferred_term: mouse
    term:
      id: NCBITaxon:10090
      label: Mus musculus
  data_type: SINGLE_CELL_RNA_SEQ
  sample_types:
  - preferred_term: Endothelial cell
    cell_type_term:
      preferred_term: endothelial cell
      term:
        id: CL:0000115
        label: endothelial cell
  - preferred_term: Pericyte
    cell_type_term:
      preferred_term: pericyte
      term:
        id: CL:0000669
        label: pericyte
  conditions:
  - Blood-labyrinth barrier
  - Stria vascularis
- accession: GSE295480
  title: Ototoxicity-induced c-Fos activation underlies regenerative capacity in vestibular sensory epithelia
  description: &gt;
    RNA sequencing of neonatal mouse utricle vestibular sensory epithelia
    examining the role of c-Fos activation in vestibular hair cell
    regeneration following gentamicin-induced ototoxic injury. Relevant
    to understanding regenerative potential in vestibular damage as
    occurs in labyrinthitis.
  organism:
    preferred_term: mouse
    term:
      id: NCBITaxon:10090
      label: Mus musculus
  data_type: BULK_RNA_SEQ
  sample_types:
  - preferred_term: Vestibular hair cell
    cell_type_term:
      preferred_term: vestibular hair cell
      term:
        id: CL:0000609
        label: vestibular hair cell
  conditions:
  - Ototoxic vestibular injury
  - Hair cell regeneration
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Labyrinthitis.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
    <script>
        (function() {
            const banner = document.querySelector('.notice-banner');
            if (!banner) return;
            const dismiss = () => banner.remove();
            banner.addEventListener('click', dismiss);
            banner.addEventListener('keydown', (event) => {
                if (event.key === 'Enter' || event.key === ' ') {
                    event.preventDefault();
                    dismiss();
                }
            });
        })();
    </script>
</body>
</html>